<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">mT97hDtFhwDvcWgrvtgMsmx</article-id>
      <article-id pub-id-type="other">00018</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2010000100018</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(10)09400118</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2010000100018</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Avalia&#231;&#227;o ecocardiogr&#225;fica da terapia de ressincroniza&#231;&#227;o card&#237;aca: dois anos de seguimento</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Veiga</surname>
            <given-names>Viviane Cordeiro</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rojas</surname>
            <given-names>Salom&#243;n Soriano Ordinola</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Souza</surname>
            <given-names>Fernando S&#233;rgio Oliva de</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vieira</surname>
            <given-names>Reinaldo Wilson</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Silva Junior</surname>
            <given-names>Amilton</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Patr&#237;cio</surname>
            <given-names>Marcelo Luiz</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marum</surname>
            <given-names>Elias C&#233;sar Hauy</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Abensur</surname>
            <given-names>Henry</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
      </contrib-group>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Benem&#233;rita Sociedade de Benefic&#234;ncia Portuguesa de S&#227;o Paulo</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Estadual de Campinas</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>01</month>
        <year>2010</year>
      </pub-date>
      <volume>94</volume>
      <issue>1</issue>
      <fpage>119</fpage>
      <lpage>126</lpage>
      <history>
        <date date-type="accepted">
          <day>22</day>
          <month>06</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>05</day>
          <month>06</month>
          <year>2009</year>
        </date>
        <date date-type="received">
          <day>20</day>
          <month>01</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: A terapia de ressincroniza&#231;&#227;o card&#237;aca (TRC) &#233; uma op&#231;&#227;o efetiva para os pacientes com insufici&#234;ncia card&#237;aca (IC) avan&#231;ada. Crit&#233;rios cl&#237;nicos, eletrocardiogr&#225;ficos e ecocardiogr&#225;ficos t&#234;m sido estudados na tentativa de selecionar os pacientes que ser&#227;o beneficiados com a TRC, sendo o ecocardiograma um m&#233;todo utilizado tanto na sele&#231;&#227;o quanto na avalia&#231;&#227;o desta terap&#234;utica. OBJETIVO: O objetivo deste trabalho &#233; analisar a utiliza&#231;&#227;o do ecocardiograma na avalia&#231;&#227;o da TRC, no seguimento de dez dias e ap&#243;s dois anos de evolu&#231;&#227;o. M&#201;TODOS: Foram avaliados 20 pacientes submetidos &#224; TRC, por um per&#237;odo de dois anos, sendo 80% do sexo masculino. Foi aplicado o Question&#225;rio de Qualidade de Vida de Minnesota, o teste de caminhada de seis minutos e realizado o ecodopplercardiograma bidimensional. Dez dias ap&#243;s o implante do marca-passo biventricular, bem como dois anos depois, foi repetida a avalia&#231;&#227;o inicial. RESULTADOS: Em dois anos, 5 pacientes (25%) foram a &#243;bito; 4 apresentavam cardiomiopatia de etiologia chag&#225;sica. N&#227;o houve altera&#231;&#227;o estatisticamente significante da fra&#231;&#227;o de eje&#231;&#227;o entre o per&#237;odo pr&#233;-operat&#243;rio e os dez dias seguintes, mas sim uma altera&#231;&#227;o significante nos per&#237;odos de pr&#233;-operat&#243;rio e dois anos e de dez dias e dois anos. No seguimento de dez dias, houve piora da dissincronia intraventricular avaliada pelo Doppler tecidual, assim como a pontua&#231;&#227;o no escore de qualidade de vida foi maior no grupo &#243;bito. CONCLUS&#195;O: Dos par&#226;metros ecocardiogr&#225;ficos avaliados, somente a avalia&#231;&#227;o da dissincronia intraventricular pelo Doppler tecidual ap&#243;s o procedimento foi capaz de predizer a efic&#225;cia da TRC em rela&#231;&#227;o &#224; mortalidade.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Ecocardiografia</kwd>
        <kwd>insufici&#234;ncia card&#237;aca</kwd>
        <kwd>volume sist&#243;lico</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>22</day>
        <month>09</month>
        <year>2010</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>ARTIGO ORIGINAL </p>
    <p> RESSINCRONIZADOR</p>
    <p>
      <bold>Avalia&#231;&#227;o ecocardiogr&#225;fica da terapia de ressincroniza&#231;&#227;o card&#237;aca: dois anos de seguimento</bold>
    </p>
    <p>
      <bold>Viviane Cordeiro Veiga<sup>I, II</sup>; Salom&#243;n Soriano Ordinola Rojas<sup>I, II</sup>; Fernando S&#233;rgio Oliva de Souza<sup>II</sup>; Reinaldo Wilson Vieira<sup>I</sup>; Amilton Silva Junior<sup>II</sup>; Marcelo Luiz Patr&#237;cio<sup>II</sup>; Elias C&#233;sar Hauy Marum<sup>II</sup>; Henry Abensur<sup>II</sup></bold>
    </p>
    <p><sup>I</sup>Universidade Estadual de Campinas (UNICAMP)- S&#227;o Paulo, SP - Brasil </p>
    <p><sup>II</sup>Real e Benem&#233;rita Associa&#231;&#227;o Portuguesa de Benefic&#234;ncia - S&#227;o Paulo, SP - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="back">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO:</bold> A terapia de ressincroniza&#231;&#227;o card&#237;aca (TRC) &#233; uma op&#231;&#227;o efetiva para os pacientes com insufici&#234;ncia card&#237;aca (IC) avan&#231;ada. Crit&#233;rios cl&#237;nicos, eletrocardiogr&#225;ficos e ecocardiogr&#225;ficos t&#234;m sido estudados na tentativa de selecionar os pacientes que ser&#227;o beneficiados com a TRC, sendo o ecocardiograma um m&#233;todo utilizado tanto na sele&#231;&#227;o quanto na avalia&#231;&#227;o desta terap&#234;utica. </p>
    <p><bold>OBJETIVO:</bold> O objetivo deste trabalho &#233; analisar a utiliza&#231;&#227;o do ecocardiograma na avalia&#231;&#227;o da TRC, no seguimento de dez dias e ap&#243;s dois anos de evolu&#231;&#227;o. </p>
    <p><bold>M&#201;TODOS: </bold> Foram avaliados 20 pacientes submetidos &#224; TRC, por um per&#237;odo de dois anos, sendo 80% do sexo masculino. Foi aplicado o Question&#225;rio de Qualidade de Vida de Minnesota, o teste de caminhada de seis minutos e realizado o ecodopplercardiograma bidimensional. Dez dias ap&#243;s o implante do marca-passo biventricular, bem como dois anos depois, foi repetida a avalia&#231;&#227;o inicial. </p>
    <p><bold>RESULTADOS: </bold> Em dois anos, 5 pacientes (25%) foram a &#243;bito; 4 apresentavam cardiomiopatia de etiologia chag&#225;sica. N&#227;o houve altera&#231;&#227;o estatisticamente significante da fra&#231;&#227;o de eje&#231;&#227;o entre o per&#237;odo pr&#233;-operat&#243;rio e os dez dias seguintes, mas sim uma altera&#231;&#227;o significante nos per&#237;odos de pr&#233;-operat&#243;rio e dois anos e de dez dias e dois anos. No seguimento de dez dias, houve piora da dissincronia intraventricular avaliada pelo Doppler tecidual, assim como a pontua&#231;&#227;o no escore de qualidade de vida foi maior no grupo &#243;bito. </p>
    <p><bold>CONCLUS&#195;O: </bold> Dos par&#226;metros ecocardiogr&#225;ficos avaliados, somente a avalia&#231;&#227;o da dissincronia intraventricular pelo Doppler tecidual ap&#243;s o procedimento foi capaz de predizer a efic&#225;cia da TRC em rela&#231;&#227;o &#224; mortalidade.</p>
    <p><bold>Palavras-chave: </bold> Ecocardiografia, insufici&#234;ncia card&#237;aca/ terapia, volume sist&#243;lico.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>A insufici&#234;ncia card&#237;aca (IC) &#233; uma condi&#231;&#227;o cl&#237;nica de alta morbi-mortalidade que acomete aproximadamente 23 milh&#245;es de pessoas no mundo<sup>1</sup>. Segundo o DATASUS<sup>2</sup>, no Brasil, no per&#237;odo de janeiro a julho de 2008, houve 147.348 interna&#231;&#245;es decorrentes da IC.</p>
    <p>Dentre os portadores de IC, os dist&#250;rbios de condu&#231;&#227;o intraventricular com prolongamento do complexo QRS est&#227;o presentes em torno de 25-50% dos pacientes<sup>3-6</sup>, sendo mais frequente o bloqueio de ramo esquerdo (BRE)<sup>6,7</sup>.</p>
    <p>A condu&#231;&#227;o do est&#237;mulo el&#233;trico est&#225; relacionada &#224; efici&#234;ncia funcional card&#237;aca. Em pacientes em que h&#225; altera&#231;&#227;o na condu&#231;&#227;o normal do est&#237;mulo, pode haver interfer&#234;ncia na coordena&#231;&#227;o contr&#225;til atrial e/ou ventricular -denominada dissincronia card&#237;aca - e, deste modo, alterar a fun&#231;&#227;o mioc&#225;rdica<sup>8,9</sup>.</p>
    <p>Cazeau e cols.<sup>10</sup>, em 1994, descreveram a estimula&#231;&#227;o do ventr&#237;culo esquerdo por meio do seio coronariano, com marca-passo tetrac&#226;mara. Em 2001, a terapia de ressincroniza&#231;&#227;o card&#237;aca (TRC) foi aprovada para uso cl&#237;nico pelo <italic>Food and Drug Administration</italic> (FDA), com mais de 270.000 pacientes j&#225; submetidos ao procedimento<sup>11</sup>. No Brasil, segundo Pach&#243;n e cols.<sup>12</sup>, no per&#237;odo de 1994 a 2006, houve 2.180 implantes de ressincronizadores. Atualmente, a TRC, por meio da estimula&#231;&#227;o card&#237;aca com marca-passo biventricular, tem sido utilizada como terapia adjuvante nos pacientes refrat&#225;rios &#224; terapia medicamentosa otimizada<sup>13,14</sup>.</p>
    <p>Bakker e cols.<sup>15</sup>, analisando 5 pacientes portadores de cardiomiopatia dilatada, com QRS largo e refratariedade &#224; terap&#234;utica medicamentosa, foram os primeiros autores a demonstrar correla&#231;&#227;o entre a estimula&#231;&#227;o biventricular e a melhora no desempenho card&#237;aco. A partir de ent&#227;o, foram publicados diversos estudos para avalia&#231;&#227;o dos efeitos da estimula&#231;&#227;o biventricular<sup>16-18</sup>.</p>
    <p>Apesar dos benef&#237;cios comprovados da TRC<sup>16-18</sup>, aproximadamente 20-30% dos pacientes n&#227;o respondem a esta terap&#234;utica e s&#227;o denominados "n&#227;o respondedores"<sup>19,20</sup>, o que leva &#224; necessidade de adotar crit&#233;rios de sele&#231;&#227;o adicionais para identificar os pacientes que ser&#227;o beneficiados com a ressincroniza&#231;&#227;o card&#237;aca<sup>21,22</sup>.</p>
    <p>De acordo com as Diretrizes Brasileiras de Dispositivos Card&#237;acos Eletr&#244;nicos Implant&#225;veis (2007)<sup>23</sup>, a recomenda&#231;&#227;o I e o n&#237;vel de evid&#234;ncia A para a TRC &#233;: pacientes em classe funcional III ou IV (NYHA), com terapia medicamentosa otimizada, fra&#231;&#227;o de eje&#231;&#227;o <underline>&lt;</underline> 35%, ritmo sinusal e dura&#231;&#227;o do complexo QRS &gt; 150 ms ou QRS entre 120 e 150 ms, com comprova&#231;&#227;o de dissincronismo por m&#233;todo de imagem.</p>
    <p>A utiliza&#231;&#227;o da ecocardiografia como m&#233;todo complementar para indica&#231;&#227;o da TRC foi descrita pela primeira vez em 2005, no estudo CARE-HF (<italic>Cardiac Resynchronization - Heart Failure</italic>)<sup>24</sup>, que comparou o efeito da TRC no risco de complica&#231;&#245;es e mortalidade. In&#250;meras t&#233;cnicas ecocardiogr&#225;ficas t&#234;m sido propostas para quantificar a dissincronia ventricular, com o intuito de otimizar a sele&#231;&#227;o dos pacientes para TRC<sup>25</sup>.</p>
    <p>Pitzalis e cols.<sup>26</sup> utilizaram o modo unidimensional (modo M) para avalia&#231;&#227;o da dissincronia intraventricular, considerando anormal valores superiores a 130 ms. O Doppler puls&#225;til &#233; um m&#233;todo ecocardiogr&#225;fico utilizado como avalia&#231;&#227;o da dissincronia interventricular<sup>24</sup>, por meio da diferen&#231;a do atraso eletromec&#226;nico entre os ventr&#237;culos direito e esquerdo, indicando dissincronia quando valores superiores a 40 ms<sup>19,25</sup>.</p>
    <p>O ecocardiograma tamb&#233;m &#233; utilizado na avalia&#231;&#227;o da regurgita&#231;&#227;o mitral. Breithardt e cols.<sup>27</sup> estudaram seus efeitos agudos na TRC, avaliando 24 pacientes submetidos &#224; ressincroniza&#231;&#227;o, os quais apresentaram redu&#231;&#227;o significativa do grau de insufici&#234;ncia mitral, diretamente relacionada ao aumento do dP/dt.</p>
    <p>O Doppler tecidual permite identificar e medir a velocidade de movimenta&#231;&#227;o do mioc&#225;rdio, posicionando-se o cursor no segmento que se deseja avaliar<sup>28</sup>. Bax e cols.<sup>19</sup>, em estudo com 85 pacientes durante 6 meses de seguimento ap&#243;s a TRC, demonstraram, entre quatro segmentos basais, sensibilidade e especifidade de 80% como preditor de melhora cl&#237;nica e 92% como preditor de remodelamento reverso, na presen&#231;a de intervalo maior que 65 ms e avaliado pelo Doppler tecidual.</p>
    <p>
      <bold>Objetivo</bold>
    </p>
    <p>O objetivo deste trabalho &#233; analisar a utiliza&#231;&#227;o do ecocardiograma na avalia&#231;&#227;o da terapia de ressincroniza&#231;&#227;o card&#237;aca, em pacientes portadores de IC refrat&#225;ria, no seguimento a curto prazo (dez dias) e ap&#243;s dois anos de evolu&#231;&#227;o.</p>
    <p>
      <bold>M&#233;todo</bold>
    </p>
    <p>Foram estudados 20 pacientes, com indica&#231;&#227;o de implante de marca-passo biventricular, por meio do seio coron&#225;rio, para terapia de ressincroniza&#231;&#227;o card&#237;aca, com idade m&#233;dia de 59,70 &#177; 12,59 anos, sendo 16 (80%) do sexo masculino, acompanhados pelo per&#237;odo de dois anos. A etiologia da cardiomiopatia era isqu&#234;mica em 10 pacientes (50%), chag&#225;sica em 6 (30%) e idiop&#225;tica em 4 (20%). Quinze pacientes (75%) encontravam-se em classe funcional III e 5 (25%) em classe funcional IV, no momento da indica&#231;&#227;o da terapia de ressincroniza&#231;&#227;o.</p>
    <p>
      <bold>Din&#226;mica do estudo</bold>
    </p>
    <p>Por ocasi&#227;o da indica&#231;&#227;o da TRC, os pacientes foram submetidos &#224; anamnese e a exame cl&#237;nico e classificados, segundo a <italic>New York Heart Association</italic> (NYHA), para avalia&#231;&#227;o funcional. Ap&#243;s avalia&#231;&#227;o cl&#237;nica inicial, foi aplicado o Question&#225;rio de Qualidade de Vida de Minnesota, determinada a dist&#226;ncia percorrida (em metros, pelo teste de caminhada de seis minutos) e realizado o ecodopplercardiograma bidimensional, utilizando-se transdutor de 3,5 Hz no aparelho Nemio (Toshiba). Dez dias ap&#243;s o implante do marca-passo biventricular, repetiu-se toda a avalia&#231;&#227;o inicial, o mesmo sendo feito ap&#243;s dois anos.</p>
    <p>
      <bold>Avalia&#231;&#227;o ecocardiogr&#225;fica</bold>
    </p>
    <p>
      <bold>Avalia&#231;&#227;o da fun&#231;&#227;o ventricular esquerda</bold>
    </p>
    <p>A avalia&#231;&#227;o da fra&#231;&#227;o de eje&#231;&#227;o do ventr&#237;culo esquerdo foi realizada pelo m&#233;todo bidimensional (m&#233;todo de Simpson). Al&#233;m disso, foi realizado o c&#225;lculo do &#237;ndice de performance mioc&#225;rdica (ou &#237;ndice de Tei), para avalia&#231;&#227;o das fun&#231;&#245;es sist&#243;lica e diast&#243;lica do ventr&#237;culo esquerdo, calculado pela soma dos tempos de contra&#231;&#227;o e de relaxamento isovolum&#233;tricos divididos pelo tempo de eje&#231;&#227;o, considerando-se normal valores menores que 0,40.</p>
    <p>
      <bold>Avalia&#231;&#227;o do remodelamento reverso</bold>
    </p>
    <p>O remodelamento reverso &#233; caracterizado pela diminui&#231;&#227;o superior a 15% do volume sist&#243;lico final, avaliado pelo ecocardiograma, entre os per&#237;odos pr&#233; e p&#243;s-operat&#243;rio.</p>
    <p>
      <bold>Avalia&#231;&#227;o da regurgita&#231;&#227;o mitral</bold>
    </p>
    <p>A avalia&#231;&#227;o da regurgita&#231;&#227;o mitral foi realizada utilizando-se o mapeamento de fluxo a cores nos cortes paraesternal longitudinal e apical de quatro c&#226;maras. A quantifica&#231;&#227;o da regurgita&#231;&#227;o mitral foi realizada por meio da rela&#231;&#227;o da &#225;rea do jato regurgitante com a &#225;rea do &#225;trio esquerdo, considerando-se regurgita&#231;&#227;o de grau discreto quando a &#225;rea percentual for menor que 20%, e importante quando for maior que 40%.</p>
    <p>
      <bold>Avalia&#231;&#227;o da dissincronia interventricular</bold>
    </p>
    <p>A dissincronia interventricular foi analisada pelo Doppler puls&#225;til, por meio da diferen&#231;a do atraso eletromec&#226;nico entre os ventr&#237;culos direito e esquerdo, medindo-se o intervalo de tempo entre a onda R do eletrocardiograma e o in&#237;cio da curva de velocidade do fluxo a&#243;rtico e do fluxo pulmonar. Intervalo superior a 40 ms &#233; indicativo de dissincronia interventricular.</p>
    <p>
      <bold>Avalia&#231;&#227;o da dissincronia intraventricular</bold>
    </p>
    <p>A avalia&#231;&#227;o da dissincronia intraventricular foi realizada pelo modo M e pelo Doppler tecidual. No corte paraesternal eixo curto, ao n&#237;vel dos m&#250;sculos papilares, foi realizada a avalia&#231;&#227;o pelo modo M, medindo-se o intervalo de tempo entre a contra&#231;&#227;o m&#225;xima do septo e da parede posterior do ventr&#237;culo esquerdo (S/PP), considerando-se dissincronia valores superiores a 130 ms. Na avalia&#231;&#227;o pelo Doppler tecidual, s&#227;o obtidas as velocidades do mioc&#225;rdio, no plano apical, dos segmentos basais das paredes septal, lateral, anterior e inferior, e realizada a medida do intervalo de tempo entre o in&#237;cio do complexo QRS at&#233; o pico da onda sist&#243;lica mioc&#225;rdica do Doppler tecidual (Sm) nos diferentes segmentos. Quando o valor da diferen&#231;a de intervalos de tempo for superior a 65 ms entre quaisquer segmentos avaliados, &#233; indicativo de dissincronia significativa. Os valores considerados foram obtidos pela m&#233;dia de quatro batimentos consecutivos.</p>
    <p>
      <bold>An&#225;lise estat&#237;stica</bold>
    </p>
    <p>A an&#225;lise dos dados foi feita com o pacote estat&#237;stico SPSS (<italic>Statistical Package for Social Sciences</italic>) <italic>for Windows</italic> vers&#227;o 11.5. Todos os testes foram realizados, considerando-se hip&#243;teses bilaterais e assumindo n&#237;vel de signific&#226;ncia &#945; = 5%. Utilizou-se a estat&#237;stica descritiva para avaliar a frequ&#234;ncia, a m&#233;dia, e o desvio-padr&#227;o das vari&#225;veis de interesse. As compara&#231;&#245;es das m&#233;dias da vari&#225;vel idade foram realizadas atrav&#233;s do teste-t para amostras independentes. Com rela&#231;&#227;o &#224;s vari&#225;veis cl&#237;nicas, eletrocardiogr&#225;ficas e ecocardiogr&#225;ficas, quando estas eram quantitativas, foram analisadas pelo teste de Mann-Whitney.</p>
    <p>O teste de Qui-quadrado foi utilizado para verificar se as propor&#231;&#245;es das categorias das vari&#225;veis cl&#237;nicas e ecocardiogr&#225;ficas, quando estas eram qualitativas, eram homog&#234;neas nos grupos de interesse. Para as compara&#231;&#245;es das vari&#225;veis classe funcional, escore de qualidade de vida e dist&#226;ncia percorrida, dura&#231;&#227;o do complexo QRS e das vari&#225;veis ecocardiogr&#225;ficas - fra&#231;&#227;o de eje&#231;&#227;o, insufici&#234;ncia mitral, dissincronia interventricular, dist&#226;ncia septo/parede posterior, &#237;ndice de performance mioc&#225;rdica, volume diast&#243;lico e sist&#243;lico final, di&#226;metro diast&#243;lico do ventr&#237;culo esquerdo e doppler tecidual ao longo do tempo (pr&#233;-operat&#243;rio, 10 dias e dois anos) -, foi utilizada a ANOVA N&#195;O PARAM&#201;TRICA.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>Neste trabalho, 20 pacientes submetidos a implante de marca-passo biventricular foram acompanhados pelo per&#237;odo de dois anos. N&#227;o houve complica&#231;&#245;es relacionadas ao procedimento cir&#250;rgico, nem &#243;bitos nos primeiros 10 dias de seguimento p&#243;s-operat&#243;rio.</p>
    <p>Realizou-se an&#225;lise para avalia&#231;&#227;o do comportamento das vari&#225;veis cl&#237;nicas, eletrocardiogr&#225;ficas e ecocardiogr&#225;ficas, comparando-as no pr&#233; e p&#243;s-operat&#243;rio (10 dias depois e ap&#243;s dois anos). No momento do implante do marca-passo, 15 pacientes encontravam-se em classe funcional III; 5 em classe funcional IV; 13 pacientes (65%) apresentaram melhora da classe funcional na primeira avalia&#231;&#227;o p&#243;s-operat&#243;ria; 6 (30%) mantiveram a mesma classe funcional; e em um paciente (5%) houve piora. No seguimento de dois anos, 10 pacientes n&#227;o apresentaram altera&#231;&#227;o da classe funcional, quando comparado &#224; avalia&#231;&#227;o pr&#233;via, havendo melhora em tr&#234;s pacientes e piora em dois deles.</p>
    <p>Ao avaliarmos as vari&#225;veis ao longo do tempo, encontramos diferen&#231;as estatisticamente significantes para as vari&#225;veis: classe funcional, escore de qualidade de vida, dura&#231;&#227;o do complexo QRS, fra&#231;&#227;o de eje&#231;&#227;o, dissincronia inter e intraventricular (tempo entre contra&#231;&#227;o do septo e da parede posterior - modo M e Doppler tecidual) e di&#226;metro diast&#243;lico do ventr&#237;culo esquerdo. A <xref ref-type="table" rid="t01">Tabela 1</xref> apresenta a m&#233;dia e o desvio-padr&#227;o para cada uma das vari&#225;veis no per&#237;odo pr&#233;-operat&#243;rio, nos 10 dias que se seguiram &#224; cirurgia e dois anos ap&#243;s a TRC.</p>
    <p content-type="asset">
      <table-wrap id="t01">
        <graphic xlink:href="1678-4170-abc-94-01-0119-00018-gt01.jpg"/></table-wrap>
    </p>
    <p>A dura&#231;&#227;o m&#233;dia do complexo QRS no pr&#233;-operat&#243;rio era de 154,5 &#177; 18,48 ms; 129,0 &#177; 22,91 ms na avalia&#231;&#227;o de 10 dias; e 134,0 &#177; 24,14 ms em dois anos, com p &lt; 0,001.</p>
    <p>Quando comparados classe funcional e dura&#231;&#227;o do complexo QRS, observou-se que pacientes com dura&#231;&#227;o do QRS <underline>&gt;</underline> 160 ms apresentaram classe funcional maior, na avalia&#231;&#227;o pr&#233;-operat&#243;ria (p = 0,006), n&#227;o havendo, no entanto, diferen&#231;a estatisticamente significante nos per&#237;odos de p&#243;s-operat&#243;rio (<xref ref-type="table" rid="t2">Tabela 2</xref>).</p>
    <table-wrap id="t2">
      <graphic xlink:href="1678-4170-abc-94-01-0119-00018-gt02.jpg"/></table-wrap>
    <p>Para as vari&#225;veis classe funcional, dura&#231;&#227;o do complexo QRS e Doppler tecidual, foram observadas diferen&#231;as estatisticamente significantes entre o per&#237;odo pr&#233;-operat&#243;rio e a avalia&#231;&#227;o de 10 dias ap&#243;s o procedimento, bem como entre o per&#237;odo pr&#233;-operat&#243;rio e os dois anos seguintes ao p&#243;s-implante. Entretanto, n&#227;o houve diferen&#231;a entre os per&#237;odos de 10 dias e dois anos. Para essas vari&#225;veis foi observada a diminui&#231;&#227;o das medidas ap&#243;s a interven&#231;&#227;o cir&#250;rgica, que se manteve est&#225;vel ap&#243;s dois anos. No <xref ref-type="fig" rid="fig18g01">Gr&#225;fico 1</xref>, &#233; poss&#237;vel analisar a varia&#231;&#227;o observada ao longo do tempo pela avalia&#231;&#227;o do Doppler tecidual.</p>
    <p content-type="asset">
      <fig id="fig18g01">
        <graphic xlink:href="1678-4170-abc-94-01-0119-00018-gf01.jpg"/></fig>
    </p>
    <p>Para a vari&#225;vel fra&#231;&#227;o de eje&#231;&#227;o, n&#227;o foi observada diferen&#231;a estatisticamente significante entre o pr&#233;-operat&#243;rio e os dez dias seguintes &#224; opera&#231;&#227;o, mas foram encontradas diferen&#231;as entre o per&#237;odo pr&#233;-operat&#243;rio e os dois anos seguintes e entre os dez dias e os dois anos posteriores.</p>
    <p>Foram encontradas diferen&#231;as estatisticamente significantes entre todos os per&#237;odos na avalia&#231;&#227;o das vari&#225;veis: dissincronia interventricular, dist&#226;ncia septo/parede posterior e escore de qualidade de vida. Houve, portanto, diminui&#231;&#227;o significante quando comparamos o pr&#233;-operat&#243;rio e os 10 dias seguintes e o pr&#233;-operat&#243;rio e os dois anos seguintes nas tr&#234;s vari&#225;veis analisadas. No entanto, houve aumento estatisticamente significante dos valores encontrados entre os per&#237;odos 10 dias e dois anos dessas vari&#225;veis.</p>
    <p>Na avalia&#231;&#227;o da vari&#225;vel DDVE, houve diminui&#231;&#227;o significante entre os per&#237;odos pr&#233;-operat&#243;rio e 10 dias e aumento significativo entre 10 dias e dois anos, de modo que n&#227;o existe diferen&#231;a estatisticamente significante entre as medidas inicial e final.</p>
    <p>Em nossa casu&#237;stica, tivemos 5 pacientes (25%) que foram a &#243;bito. Na <xref ref-type="table" rid="t3">Tabela 3</xref>, observa-se que a propor&#231;&#227;o de homens dentro dos grupos &#243;bito e n&#227;o &#243;bito &#233; homog&#234;nea (86,7% e 60%, respectivamente), com predomin&#226;ncia de homens em ambos os grupos, n&#227;o havendo diferen&#231;a significante entre a propor&#231;&#227;o de homens e mulheres nos dois grupos (p = 0,249).</p>
    <table-wrap id="t3">
      <graphic xlink:href="1678-4170-abc-94-01-0119-00018-gt03.jpg"/></table-wrap>
    <p>Para a vari&#225;vel etiologia, no grupo n&#227;o &#243;bito, o n&#250;mero de pacientes com etiologia dilatada e isqu&#234;mica &#233; maior que no grupo &#243;bito. Na etiologia chag&#225;sica acontece o contr&#225;rio, havendo 80% dos pacientes no grupo &#243;bito, existindo diferen&#231;a estatisticamente significante nas propor&#231;&#245;es dos tipos de etiologia segundo &#243;bito (p = 0,018).</p>
    <p>N&#227;o houve diferen&#231;a estatisticamente significante entre os grupos &#243;bito e n&#227;o &#243;bito para as vari&#225;veis insufici&#234;ncia mitral e dura&#231;&#227;o do complexo QRS, tanto no per&#237;odo pr&#233;-operat&#243;rio quanto ap&#243;s 10 dias.</p>
    <p>Na <xref ref-type="table" rid="t04">Tabela 4</xref>, encontram-se as compara&#231;&#245;es das vari&#225;veis classe funcional, escore de qualidade de vida, dist&#226;ncia percorrida, dissincronia interventricular, dist&#226;ncia septo/parede posterior, &#237;ndice de performance mioc&#225;rdica, volume diast&#243;lico e sist&#243;lico final e Doppler tecidual nos per&#237;odos pr&#233;-operat&#243;rio e 10 dias ap&#243;s a cirurgia.</p>
    <p content-type="asset">
      <table-wrap id="t04">
        <graphic xlink:href="1678-4170-abc-94-01-0119-00018-gt04.jpg"/></table-wrap>
    </p>
    <p>N&#227;o houve diferen&#231;a estatisticamente significante entre os grupos &#243;bito e n&#227;o &#243;bito, na avalia&#231;&#227;o das vari&#225;veis no pr&#233;-operat&#243;rio. Entretanto, na avalia&#231;&#227;o de 10 dias, houve diferen&#231;a estatisticamente significante na vari&#225;vel escore de qualidade de vida, sendo que os pacientes do grupo &#243;bito possuem uma pontua&#231;&#227;o maior no escore de qualidade de vida em rela&#231;&#227;o ao grupo n&#227;o &#243;bito. O mesmo &#233; verificado para a vari&#225;vel Doppler tecidual, em que o grupo &#243;bito apresentou valores que sugeriam maior dissincronismo intraventricular.</p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>A IC &#233; um grave problema de sa&#250;de p&#250;blica, com elevada morbi-mortalidade e custos superiores a 33 bilh&#245;es de d&#243;lares por ano<sup>1</sup>.</p>
    <p>Em cerca de 25-50% dos portadores de IC, h&#225; presen&#231;a de dist&#250;rbio de condu&#231;&#227;o intraventricular, sendo mais frequente o bloqueio de ramo esquerdo. Baldasseroni e cols.<sup>7</sup>, em 2002, avaliaram a associa&#231;&#227;o de BRE e mortalidade e demonstraram que o BRE &#233; um marcador progn&#243;stico desfavor&#225;vel e independente de idade, grau de IC e uso de terap&#234;utica.</p>
    <p>Atualmente, a TRC tem sido utilizada como adjuvante nos pacientes com IC refrat&#225;rios &#224; terapia medicamentosa otimizada<sup>16,18</sup>.</p>
    <p>Em nossa casu&#237;stica, avaliamos 20 pacientes, sendo 15 em classe funcional III e 5 em classe funcional IV, submetidos &#224; TRC por meio do seio coron&#225;rio, n&#227;o havendo complica&#231;&#245;es inerentes ao procedimento. Todos os pacientes apresentavam BRE no eletrocardiograma, com dura&#231;&#227;o do complexo QRS superior a 120 ms.</p>
    <p>Apesar dos benef&#237;cios comprovados da TRC<sup>16-18</sup>, aproximadamente 20-30% dos pacientes n&#227;o respondem a esta terap&#234;utica<sup>19,20</sup>, necessitando implementar crit&#233;rios adicionais para identificar os pacientes que ser&#227;o beneficiados<sup>21,22</sup>.</p>
    <p>Nesta casu&#237;stica, no seguimento de 10 dias ap&#243;s o implante do marca-passo biventricular, houve melhora da classe funcional em 13 pacientes (65%), piora em um deles (5%) e em 6 pacientes (30%) a classe funcional permaneceu inalterada. Ap&#243;s dois anos de evolu&#231;&#227;o, 8 pacientes apresentavam-se em classe funcional II e 7 em classe funcional III. A mortalidade nesse per&#237;odo foi de 25% (5 pacientes), n&#227;o havendo correla&#231;&#227;o entre &#243;bito e a piora da classe funcional.</p>
    <p>Na avalia&#231;&#227;o da etiologia da cardiomiopatia, Reuter e cols.<sup>29</sup> associaram a cardiomiopatia dilatada &#224; melhor resposta cl&#237;nica da TRC. Martinelli Filho e cols.<sup>30</sup>, em estudo incluindo pacientes com etiologia chag&#225;sica, encontraram redu&#231;&#227;o significativa da classe funcional em pacientes com cardiomiopatia dilatada, al&#233;m desta etiologia ter sido um preditor independente de melhora cl&#237;nica.</p>
    <p>Dentre os pacientes deste estudo, os que apresentaram etiologia chag&#225;sica estiveram relacionados &#224; maior taxa de &#243;bito, com diferen&#231;a estatisticamente significante quando comparados aos pacientes com etiologia isqu&#234;mica e dilatada.</p>
    <p>Shamim e cols.<sup>8</sup> avaliaram, em 36 meses de seguimento, a associa&#231;&#227;o entre dura&#231;&#227;o do QRS e mortalidade, onde pacientes com QRS menor que 120 ms apresentaram mortalidade de 20%; QRS entre 120 e 160 ms, 36%; e acima de 160 ms, a mortalidade foi de 58%<sup>31</sup>.</p>
    <p>Em nossa casu&#237;stica, comparando classe funcional e dura&#231;&#227;o do QRS, foi encontrada diferen&#231;a estatisticamente significante entre os grupos no per&#237;odo pr&#233;-TRC, onde o grupo com QRS <underline>&gt;</underline> 160 ms apresentava pior classe funcional<sup>31</sup>. No seguimento de 10 dias, n&#227;o houve diferen&#231;a estatisticamente significante entre os dois grupos. Em dois anos de avalia&#231;&#227;o, havia somente um paciente vivo com dura&#231;&#227;o do QRS superior a 160 ms.</p>
    <p>Diversas t&#233;cnicas ecocadiogr&#225;ficas t&#234;m sido utilizadas na quantifica&#231;&#227;o das dissincronias inter e intraventricular, com o intuito de otimizar a sele&#231;&#227;o dos pacientes para TRC.</p>
    <p>A avalia&#231;&#227;o da dissincronia interventricular com a utiliza&#231;&#227;o do modo M do ecocardiograma (S/PP) foi proposta por Pitzalis e cols.<sup>26</sup> - em um grupo de 20 pacientes, todos os respondedores apresentavam dist&#226;ncia S/PP superior a 130 ms.</p>
    <p>Neste ensaio, tivemos uma diminui&#231;&#227;o estatisticamente significante nos valores da vari&#225;vel S/PP, quando comparados os tr&#234;s per&#237;odos de an&#225;lise. No entanto, n&#227;o houve diferen&#231;a estat&#237;stica no grupo &#243;bito comparado ao grupo n&#227;o &#243;bito nas avalia&#231;&#245;es de pr&#233;-operat&#243;rio e no seguimento de 10 dias. Em pacientes com cardiomiopatia isqu&#234;mica, a an&#225;lise da vari&#225;vel S/PP pode estar prejudicada por altera&#231;&#245;es da contra&#231;&#227;o segmentar.</p>
    <p>Com o Doppler pulsatil, Chung e cols.<sup>32</sup> mostraram a rela&#231;&#227;o dessa vari&#225;vel com melhora cl&#237;nica e remodelamento reverso.</p>
    <p>Em nosso grupo, houve diferen&#231;a estatisticamente significante no pr&#233;-operat&#243;rio e nos dois per&#237;odos de avalia&#231;&#227;o p&#243;s-operat&#243;ria. No entanto, relacionando os valores entre os grupos &#243;bito e n&#227;o &#243;bito, n&#227;o houve diferen&#231;a estatisticamente significante.</p>
    <p>Na avalia&#231;&#227;o da regurgita&#231;&#227;o mitral, em 10 dias, 11 pacientes n&#227;o apresentaram mudan&#231;as no grau de regurgita&#231;&#227;o mitral. No seguimento de dois anos, 10 pacientes encontravam-se com o mesmo grau de regurgita&#231;&#227;o que apresentavam no pr&#233;-operat&#243;rio no primeiro seguimento (10 dias) e posterior piora na avalia&#231;&#227;o de dois anos. Quando comparados os grupos &#243;bito e n&#227;o &#243;bito, a insufici&#234;ncia mitral n&#227;o teve valor estatisticamente significante.</p>
    <p>Em estudo com 85 pacientes, em seguimento de 6 meses p&#243;s-TRC, Bax e cols.<sup>19</sup> demonstraram sensibilidade e especificidade de 80% como preditor de melhora cl&#237;nica e 92% de sensibilidade e especificidade para predizer remodelamento reverso, quando o valor da dissincronia avaliada pelo Doppler tecidual era superior a 65 ms.</p>
    <p>Em nosso grupo, tivemos diferen&#231;a estatisticamente significante na varia&#231;&#227;o do Doppler tecidual de pr&#233; e p&#243;s-operat&#243;rio, podendo-se considerar que a avalia&#231;&#227;o do Doppler tecidual nos primeiros dias p&#243;s-procedimento &#233; uma ferramenta &#250;til na avalia&#231;&#227;o da efic&#225;cia da TRC. Quando comparado o grupo &#243;bito e n&#227;o &#243;bito, o Doppler tecidual mostrou aumento relacionado ao grupo &#243;bito.</p>
    <p>Neste estudo, n&#227;o foram utilizadas t&#233;cnicas mais avan&#231;adas de ecocardiografia, como o ecocardiograma tridimensional e o <italic>strain</italic> bidimensional, o que, no futuro, poder&#225; ampliar a atua&#231;&#227;o da ecocardiografia na avalia&#231;&#227;o dos pacientes para TRC.</p>
    <p>
      <bold>Limita&#231;&#245;es do estudo</bold>
    </p>
    <p>- Casu&#237;stica pequena, com aus&#234;ncia de grupo controle;</p>
    <p>- Avalia&#231;&#227;o ecocardiogr&#225;fica sem estudo de reprodutibilidade intra e inter-observador.</p>
    <p>
      <bold>Conclus&#227;o</bold>
    </p>
    <p>Na avalia&#231;&#227;o ecocardiogr&#225;fica dos par&#226;metros avaliados neste estudo, somente a dissincronia intraventricular pelo Doppler tecidual ap&#243;s o procedimento foi capaz de predizer a efic&#225;cia da terapia de ressincroniza&#231;&#227;o card&#237;aca em rela&#231;&#227;o &#224; mortalidade. Os par&#226;metros ecocardiogr&#225;ficos n&#227;o se correlacionaram com a melhora cl&#237;nica.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de disserta&#231;&#227;o de Mestrado de Viviane Cordeiro Veiga pela Universidade Estadual de Campinas.</p>
    <p>
      <fn id="back" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p> Viviane Cordeiro Veiga </p>
        <p> Alameda It&#225;lia, 430 - Alphaville Resid 1 </p>
        <p> 06474-140 - Barueri, SP - Brasil </p>
        <p> E-mail: </p>
        <p><email xlink:href="vcveiga@cardiol.br">vcveiga@cardiol.br</email>, </p>
        <p>
          <email xlink:href="dveiga@uol.com.br">dveiga@uol.com.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 20/01/09; revisado recebido em 05/06/09; aceito em 22/06/09.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. McAlister FA,    Teo KK, Taher M. Insights into the contemporary epidemiology and outpatient    management of congestive heart failure. Am Heart J. 1999; 138: 87-94.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Insights into the contemporary epidemiology and outpatient management of congestive heart failure</article-title>
          <source>Am Heart J</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>87</fpage>
          <lpage>94</lpage>
          <volume>138</volume>
          <person-group person-group-type="author">
            <name>
              <surname>McAlister</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Teo</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Taher</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2. Minist&#233;rio da Sa&#250;de. DATASUS. Sistema de Informa&#231;&#245;es hospitalares do SUS. [Acesso em 2009 jan 8]. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.datasus.gov.br">http://www.datasus.gov.br</ext-link>.</mixed-citation>
        <element-citation publication-type="book">
          <source>DATASUS: Sistema de Informa&#231;&#245;es hospitalares do SUS</source>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Furman S, Robinson    G. Use of intracardiac pacemaker in correction of total heart block. Surg Forum.    1958; 9: 245.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Use of intracardiac pacemaker in correction of total heart block</article-title>
          <source>Surg Forum</source>
          <date>
            <year>1958</year>
          </date>
          <fpage>245</fpage>
          <volume>9</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Furman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Horwich T, Foster    E, De Marco T, Tseng Z, Saxon L. Effects of resynchronization therapy on cardiac    function in pacemaker patients "upgraded" to biventricular devices. J Cardiovasc    Electrophysiol. 2004; 15 (11): 1284-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effects of resynchronization therapy on cardiac function in pacemaker patients "upgraded" to biventricular devices</article-title>
          <source>J Cardiovasc Electrophysiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1284</fpage>
          <lpage>9</lpage>
          <issue>11</issue>
          <volume>15</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Horwich</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Foster</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>De Marco</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tseng</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Saxon</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Aaronson KD,    Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective    validation of a clinical index to predict survival in ambulatory patients referred    for cardiac transplant evaluation. Circulation. 1997; 95 (12): 2660-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation</article-title>
          <source>Circulation</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>2660</fpage>
          <lpage>7</lpage>
          <issue>12</issue>
          <volume>95</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Aaronson</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Goin</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Mancini</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Leclercq C,    Hare JM. Ventricular resynchronization: current state of the art. Circulation.    2004; 109 (3): 296-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ventricular resynchronization: current state of the art</article-title>
          <source>Circulation</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>296</fpage>
          <lpage>9</lpage>
          <issue>3</issue>
          <volume>109</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Leclercq</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hare</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Baldasseroni    S, Opasich C, Gorini M, Lucci D, Marchionni M, Marini M, et al. Left bundle-branch    block is associated with increased 1-year sudden and total mortality rate in    5517 outpatients with congestive heart failure: a report from the Italian Network    on congestive heart failure. Am Heart J. 2002; 143 (3): 398-405.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian Network on congestive heart failure</article-title>
          <source>Am Heart J</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>398</fpage>
          <lpage>405</lpage>
          <issue>3</issue>
          <volume>143</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Baldasseroni</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Opasich</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gorini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lucci</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Marchionni</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marini</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Shamim W, Francis    DP, Yousufuddin M, Varney S, Pieopli MF, Anker SD, et al. Intraventricular conduction    delay: a prognostic marker in chronic heart failure. Int J Cardiol. 1999; 70    (2): 171-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Intraventricular conduction delay: a prognostic marker in chronic heart failure</article-title>
          <source>Int J Cardiol</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>171</fpage>
          <lpage>8</lpage>
          <issue>2</issue>
          <volume>70</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Shamim</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Francis</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Yousufuddin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Varney</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pieopli</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Anker</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Rosenqvist M,    Isaaz K, Botvinick EH, Dae MW, Cockrell J, Aboot JA, et al. Relative importance    of activation sequence compared to atrioventricular synchrony in left ventricular    function. Am J Cardiol. 1991; 67: 148-56.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Relative importance of activation sequence compared to atrioventricular synchrony in left ventricular function</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>148</fpage>
          <lpage>56</lpage>
          <volume>67</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rosenqvist</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Isaaz</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Botvinick</surname>
              <given-names>EH</given-names>
            </name>
            <name>
              <surname>Dae</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Cockrell</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Aboot</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Cazeau, S,    Ritter P, Bakdach S. Four chamber pacing in dilated cardiomyopathy. Pacing Clin    Electrophysiol. 1994; 17 (11 Pt 2): 1974-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Four chamber pacing in dilated cardiomyopathy</article-title>
          <source>Pacing Clin Electrophysiol</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>1974</fpage>
          <lpage>9</lpage>
          <issue>11</issue>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cazeau</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ritter</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bakdach</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Aranda JM,    Woo GW, Schofield RS, Handberg EM, Hill JA, Curtis AB, et al. Management of    heart failure after cardiac resynchronization therapy: integrating advanced    heart failure treatment with optimal device function. J Am Coll Cardiol, 2005;    46 (12): 2193-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Management of heart failure after cardiac resynchronization therapy: integrating advanced heart failure treatment with optimal device function</article-title>
          <source>J Am Coll Cardiol,</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>2193</fpage>
          <lpage>8</lpage>
          <issue>12</issue>
          <volume>46</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Aranda</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Woo</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Schofield</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Handberg</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Curtis</surname>
              <given-names>AB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Pach&#243;n    MJC, Mosqu&#233;ra JAP, Pach&#243;n MJC, Vargas RNA, Campos Neto CM, Costa    ARB. Aspectos epidemiol&#243;gicos da estimula&#231;&#227;o card&#237;aca    no Brasil - 12&#351; ano do RBM - Registro brasileiro de marcapassos, desfibriladores    e ressincronizadores card&#237;acos. Relampa. 2008; 21 (1): 5-12.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Aspectos epidemiol&#243;gicos da estimula&#231;&#227;o card&#237;aca no Brasil - 12&#186; ano do RBM - Registro brasileiro de marcapassos, desfibriladores e ressincronizadores card&#237;acos</article-title>
          <source>Relampa</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>5</fpage>
          <lpage>12</lpage>
          <issue>1</issue>
          <volume>21</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pach&#243;n</surname>
              <given-names>MJC</given-names>
            </name>
            <name>
              <surname>Mosqu&#233;ra</surname>
              <given-names>JAP</given-names>
            </name>
            <name>
              <surname>Pach&#243;n</surname>
              <given-names>MJC</given-names>
            </name>
            <name>
              <surname>Vargas</surname>
              <given-names>RNA</given-names>
            </name>
            <name>
              <surname>Campos Neto</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>ARB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. D&#237;az-Infante    E, Hern&#225;ndez-Madrid A, Brugada-Terradellas J, F&#233;rnandez-Lozano    I, Garc&#237;a-Bolao I, Del Ojo JL, et al. Consenso sobre la terapia de resincronizaci&#243;n    card&#237;aca. Rev Esp Cardiol. 2005; 5 (Supl): 3B-11B.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Consenso sobre la terapia de resincronizaci&#243;n card&#237;aca</article-title>
          <source>Rev Esp Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>3B</fpage>
          <lpage>11B</lpage>
          <volume>5</volume>
          <person-group person-group-type="author">
            <name>
              <surname>D&#237;az-Infante</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hern&#225;ndez-Madrid</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brugada-Terradellas</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>F&#233;rnandez-Lozano</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Garc&#237;a-Bolao</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Del Ojo</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Brito Jr HL,    Bianchi FN, Nascimento LEP, Toledo RM, Barral MM. Estimula&#231;&#227;o    card&#237;aca artificial como tratamento dos pacientes com miocardiopatia    dilatada e insufici&#234;ncia card&#237;aca. Novos conceitos, novas t&#233;cnicas    e necessidades de atualiza&#231;&#227;o. Reblampa. 2000; 13 (4): 185-93.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Estimula&#231;&#227;o card&#237;aca artificial como tratamento dos pacientes com miocardiopatia dilatada e insufici&#234;ncia card&#237;aca: Novos conceitos, novas t&#233;cnicas e necessidades de atualiza&#231;&#227;o</article-title>
          <source>Reblampa</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>185</fpage>
          <lpage>93</lpage>
          <issue>4</issue>
          <volume>13</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Brito Jr</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Bianchi</surname>
              <given-names>FN</given-names>
            </name>
            <name>
              <surname>Nascimento</surname>
              <given-names>LEP</given-names>
            </name>
            <name>
              <surname>Toledo</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Barral</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Bakker PF,    Meijburg H, Dejonge N, Mechelen RV, Wittkampf F, Mower M, et al. Beneficial    effects of biventricular pacing in congestive heart failure. [abstract]    Pacing Clin Electrophysiol. 1994; 17: 820.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Beneficial effects of biventricular pacing in congestive heart failure: [abstract]</article-title>
          <source>Pacing Clin Electrophysiol</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>820</fpage>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bakker</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Meijburg</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Dejonge</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mechelen</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Wittkampf</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Mower</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Abraham WT,    Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. for the Multicenter    InSync randomized clinical evaluation (MIRACLE) study group. Cardiac resynchronization    in chronic heart failure. N Engl J Med. 2002; 346 (24): 1845-53.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>for the Multicenter InSync randomized clinical evaluation (MIRACLE) study group: Cardiac resynchronization in chronic heart failure</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>1845</fpage>
          <lpage>53</lpage>
          <issue>24</issue>
          <volume>346</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Abraham</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Fisher</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Delurgio</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Leon</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Loh</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Bristow MR,    Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. for the Comparison    of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION)    Investigators. Cardiac-resynchronization therapy with or without an implantable    defibrillator in advanced chronic heart failure. N Engl J Med. 2004; 350 (21):    2140-50.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators: Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>2140</fpage>
          <lpage>50</lpage>
          <issue>21</issue>
          <volume>350</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bristow</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Saxon</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Boehmer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Krueger</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kass</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>De Marco</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Cazeau S, Leclercq    C, Lavergne T, Walker S, Varma C, Linde C, et al. for the Multisite Stimulation    in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular    pacing in patients with heart failure and intraventricular conduction delay.    N Engl J Med. 2001; 344 (12): 873-80.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>for the Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>873</fpage>
          <lpage>80</lpage>
          <issue>12</issue>
          <volume>344</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cazeau</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Leclercq</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lavergne</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Varma</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Linde</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Bax JJ, Bleeker    GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, et al. Left ventricular    dyssynchrony predicts response and prognosis after cardiac resynchronization    therapy. J Am Coll Cardiol. 2004; 44: 1834-40.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1834</fpage>
          <lpage>40</lpage>
          <volume>44</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bax</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Bleeker</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>Marwick</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Molhoek</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Boersma</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Steendijk</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Saxon LA, Ellenbogen    KA. Resynchronization therapy for the treatment of heart failure. Circulation.    2003; 108: 1044-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Resynchronization therapy for the treatment of heart failure</article-title>
          <source>Circulation</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1044</fpage>
          <lpage>8</lpage>
          <volume>108</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Saxon</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Ellenbogen</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Galv&#227;o    Filho SS, Vasconcelos JTM, Barcelos CB, Rabelo AC. Sele&#231;&#227;o de    pacientes e modos de estimula&#231;&#227;o card&#237;aca no tratamento    da disfun&#231;&#227;o ventricular. Rev Soc Cardiol Estado de S&#227;o    Paulo. 2004; 1: 43-54.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Sele&#231;&#227;o de pacientes e modos de estimula&#231;&#227;o card&#237;aca no tratamento da disfun&#231;&#227;o ventricular</article-title>
          <source>Rev Soc Cardiol Estado de S&#227;o Paulo</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>43</fpage>
          <lpage>54</lpage>
          <volume>1</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Galv&#227;o Filho</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Vasconcelos</surname>
              <given-names>JTM</given-names>
            </name>
            <name>
              <surname>Barcelos</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Rabelo</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. D&#237;az-Infante    E, Mont L, Leal J, Garc&#237;a-Bolao I, Fern&#225;ndez-Lozano I, Hern&#225;ndez-Madrid    A, et al. of the Spanish Cardiac Resynchronization Study (SCARS). Predictors    of lack of response to resynchronization therapy. Am J Cardiol. 2005; 95: 1436-40.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>of the Spanish Cardiac Resynchronization Study (SCARS): Predictors of lack of response to resynchronization therapy</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>1436</fpage>
          <lpage>40</lpage>
          <volume>95</volume>
          <person-group person-group-type="author">
            <name>
              <surname>D&#237;az-Infante</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mont</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Leal</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Garc&#237;a-Bolao</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Fern&#225;ndez-Lozano</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Hern&#225;ndez-Madrid</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Sociedade Brasileira    de Cardiologia. Diretrizes brasileiras de dispositivos card&#237;acos eletr&#244;nicos    implant&#225;veis. Arq Bras Cardiol. 2007; 89 (6): e210-e238.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Diretrizes brasileiras de dispositivos card&#237;acos eletr&#244;nicos implant&#225;veis</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>e210</fpage>
          <lpage>e238</lpage>
          <issue>6</issue>
          <volume>89</volume>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Cleland JGF,    Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. for the    Cardiac Resynchronization - Heart failure (CARE-HF) Study Investigators. The    effect of cardiac resynchronization on morbidity and mortality in heart failure.    N Engl J Med. 2005; 352: 1539-49.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>for the Cardiac Resynchronization - Heart failure (CARE-HF) Study Investigators: The effect of cardiac resynchronization on morbidity and mortality in heart failure</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>1539</fpage>
          <lpage>49</lpage>
          <volume>352</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cleland</surname>
              <given-names>JGF</given-names>
            </name>
            <name>
              <surname>Daubert</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Erdmann</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Freemantle</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Gras</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kappenberger</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Gorcsan IIII    J, Abraham T, Agler DA, Bax JJ, Derumeaux G, Grimm RA, et al. Echocardiography    for cardiac resynchronization therapy: recommendations for performance and reporting    - a report from the American Society of Echocardiography Dyssynchrony writing    group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr. 2008; 21    (3): 191-213.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting - a report from the American Society of Echocardiography Dyssynchrony writing group endorsed by the Heart Rhythm Society</article-title>
          <source>J Am Soc Echocardiogr</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>191</fpage>
          <lpage>213</lpage>
          <issue>3</issue>
          <volume>21</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gorcsan IIII</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Abraham</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Agler</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Bax</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Derumeaux</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Grimm</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Pitzalis MV,    Iacoviello M, Romito R, Massari F, Rizzon B, Luzzi G, et al. Cardiac resynchronization    therapy tailored by echocardiographic evaluation of ventricular asynchrony.    J Am Coll Cardiol. 2002; 40: 1615-22.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>1615</fpage>
          <lpage>22</lpage>
          <volume>40</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pitzalis</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Iacoviello</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Romito</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Massari</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rizzon</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Luzzi</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Breithdardt    OA, Sinha AM, Schwammenthal E, Bidaoui N, Markus KU, Franke A, et al. Acute    effects of cardiac resynchronization therapy on functional mitral regurgitation    in advanced systolic heart failure. J Am Coll Cardiol. 2003; 41: 765-70.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>765</fpage>
          <lpage>70</lpage>
          <volume>41</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Breithdardt</surname>
              <given-names>OA</given-names>
            </name>
            <name>
              <surname>Sinha</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Schwammenthal</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bidaoui</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Markus</surname>
              <given-names>KU</given-names>
            </name>
            <name>
              <surname>Franke</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Silva CES,    Barreto ACP. Avalia&#231;&#227;o ecocardiogr&#225;fica da terapia de ressincroniza&#231;&#227;o    card&#237;aca. Arq Bras Cardiol. 2005; 84 (6): 503-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Avalia&#231;&#227;o ecocardiogr&#225;fica da terapia de ressincroniza&#231;&#227;o card&#237;aca</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>503</fpage>
          <lpage>7</lpage>
          <issue>6</issue>
          <volume>84</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Silva</surname>
              <given-names>CES</given-names>
            </name>
            <name>
              <surname>Barreto</surname>
              <given-names>ACP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Reuter S, Garrigue    S, Barold SS, Jais P, Hocini M, Haissaguerre M, et al. Comparison of characteristics    in responders versus nonresponders with biventricular pacing for drug-resistant    congestive heart failure. Am J Cardiol. 2002; 89: 346-50.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>346</fpage>
          <lpage>50</lpage>
          <volume>89</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Reuter</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Garrigue</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Barold</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Jais</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hocini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Haissaguerre</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30. Martinelli    Filho M, Baggio Jr JM, Nishioka SAD, Pedrosa A, Torres GG, Escari&#227;o A,    et al. Ressincroniza&#231;&#227;o card&#237;aca em seguimento tardio:    an&#225;lise de preditores de resposta cl&#237;nica. Reblampa. 2006; 19    (1): 45-52.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ressincroniza&#231;&#227;o card&#237;aca em seguimento tardio: an&#225;lise de preditores de resposta cl&#237;nica</article-title>
          <source>Reblampa</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>45</fpage>
          <lpage>52</lpage>
          <issue>1</issue>
          <volume>19</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Martinelli Filho</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Baggio Jr</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Nishioka</surname>
              <given-names>SAD</given-names>
            </name>
            <name>
              <surname>Pedrosa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Torres</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Escari&#227;o</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B31">
        <mixed-citation>31. Achilli A,    Sassara M, Ficili S, Pontillo D, Achilli P, Alessi C, et al. Long-term effectiveness    of cardiac resynchronization therapy in patients with refractory heart failure    and "narrow" QRS. J Am Coll Cardiol. 2003; 42 (12): 2117-24.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>2117</fpage>
          <lpage>24</lpage>
          <issue>12</issue>
          <volume>42</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Achilli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sassara</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ficili</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pontillo</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Achilli</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Alessi</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B32">
        <mixed-citation>32. Chung ES, Leon    AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, et al. Results of the predictors    of response to CRT (PROSPECT) trial. Circulation. 2008; 117: 2608-16.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Results of the predictors of response to CRT (PROSPECT) trial</article-title>
          <source>Circulation</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>2608</fpage>
          <lpage>16</lpage>
          <volume>117</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Chung</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Leon</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Tavazzi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Nihoyannopoulos</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Merlino</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Echocardiographic assessment of cardiac resynchronization therapy: two-year follow-up period</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: The cardiac resynchronization therapy (CRT) is an effective option for patients with advanced heart failure (HF). Clinical, electrocardiographic and echocardiographic criteria have been studied in an attempt to find the patients that will benefit from the CRT, considering that the echocardiogram is the method that is used both in the selection and in the assessment of such therapy. OBJECTIVE: The objective of this work is to analyze the use of echocardiogram to assess the CRT, in a ten-day follow-up period and after two years of evolution. METHODS: The assessment considered 20 patients subjected to CRT, for a period of two years, 80% of which were male. The Minnesota Living with Heart Failure Questionnaire (MLWHF) was filled out. Patients underwent a six-minute walking test. Then, the two-dimensional echo-Doppler-cardiogram was performed. The initial assessment was repeated ten days after and two year after the implantation of the biventricular pacemaker. RESULTS: In two years, 5 patients (25%) died; 4 had cardiomyopathy caused by the Chagas's disease. There was no statistically significant change in the ejection fraction between the pre-operation period and the following ten days, but there was a significant change between the pre-operation period and two years after that, and the ten-day period and two years after that. In the ten-day follow-up period, there was the worsening of the intraventricular dyssynchrony, as evaluated by the tissue Doppler method, and the "living with heart failure" score was higher in the group of deaths. CONCLUSION: Out of the echocardiographic parameters assessed, only the intraventricular dyssynchrony assessment through the tissue Doppler method, after the procedure, was capable of predict the CRT efficiency with respect to the death rate.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Echocardiography</kwd>
        <kwd>heart failure</kwd>
        <kwd>stroke volume</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <p>
        <fn id="top-body2">
          <label>
            <bold>Echocardiographic assessment of cardiac resynchronization therapy: two-year follow-up period</bold>
          </label>
          <p>
            <bold>Viviane Cordeiro Veiga<sup>I, II</sup>; Salom&#243;n Soriano Ordinola Rojas<sup>I, II</sup>; Fernando S&#233;rgio Oliva de Souza<sup>II</sup>; Reinaldo Wilson Vieira<sup>I</sup>; Amilton Silva Junior<sup>II</sup>; Marcelo Luiz Patr&#237;cio<sup>II</sup>; Elias C&#233;sar Hauy Marum<sup>II</sup>; Henry Abensur<sup>II</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Universidade Estadual de Campinas (UNICAMP)</p>
      <p><sup>II</sup>Real e Benem&#233;rita Associa&#231;&#227;o Portuguesa de Benefic&#234;ncia - S&#227;o Paulo, SP - Brazil</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND: </bold> The cardiac resynchronization therapy (CRT) is an effective option for patients with advanced heart failure (HF). Clinical, electrocardiographic and echocardiographic criteria have been studied in an attempt to find the patients that will benefit from the CRT, considering that the echocardiogram is the method that is used both in the selection and in the assessment of such therapy.</p>
      <p><bold>OBJECTIVE: </bold> The objective of this work is to analyze the use of echocardiogram to assess the CRT, in a ten-day follow-up period and after two years of evolution.</p>
      <p><bold>METHOD: </bold> The assessment considered 20 patients subjected to CRT, for a period of two years, 80% of which were male. The Minnesota Living with Heart Failure Questionnaire (MLWHF) was filled out. Patients underwent a six-minute walking test. Then, the two-dimensional echo-Doppler-cardiogram was performed. The initial assessment was repeated ten days after and two year after the implantation of the biventricular pacemaker.</p>
      <p><bold>RESULTS: </bold> In two years, 5 patients (25%) died; 4 had cardiomyopathy caused by the Chagas's disease. There was no statistically significant change in the ejection fraction between the pre-operation period and the following ten days, but there was a significant change between the pre-operation period and two years after that, and the ten-day period and two years after that. In the ten-day follow-up period, there was the worsening of the intraventricular dyssynchrony, as evaluated by the tissue Doppler method, and the "living with heart failure" score was higher in the group of deaths.</p>
      <p><bold>CONCLUSION: </bold> Out of the echocardiographic parameters assessed, only the intraventricular dyssynchrony assessment through the tissue Doppler method, after the procedure, was capable of predict the CRT efficiency with respect to the death rate.</p>
      <p><bold>Key-Words:</bold> echocardiography; heart failure / therapy; stroke volume.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>Heart failure (HF) is a medical condition with a high morbidity-mortality rate that affects approximately 23 million people in the world<sup>1</sup>. According to DATASUS<sup>2</sup>, in Brazil, in the period between January and July 2008, 147,348 hospital admissions caused by HF.</p>
      <p>Intraventricular conduction disturbances with extension of the QRS complex are present in 25-50% of HF patients<sup>3-6</sup>, in which the most frequent case is the left bundle branch block (LBBB)<sup>6,7</sup>.</p>
      <p>The conduction of the electrical stimulus is associated with the functional cardiac efficiency. In patients in whom there is a change in the regular conduction of the stimulus, there may be some interference in the ventricular and/or atrial contractile coordination - called cardiac dyssynchrony. That may cause a change in the myocardial function<sup>8,9</sup>.</p>
      <p>Cazeau et al<sup>10</sup>, in 1994, described the stimulation of the left ventricle through the coronary sinus, with a four-chamber pacemaker. In 2001, the cardiac resynchronization therapy (CRT) was approved for clinical use by the Food and Drug Administration (FDA). After that, more than 270,000 patients have already undergone the procedure<sup>11</sup>. In Brazil, according to Pach&#243;n et al<sup>12</sup>, in the period from 1994 to 2006, 2,180 resynchronizers were implanted. Nowadays, the CRT, through heart stimulation with a biventricular pacemaker, has been used as an auxiliary therapy in patients that are refractory to optimized medication therapy<sup>13,14</sup>.</p>
      <p>Bakker et al<sup>15</sup>, in an analysis of 5 patients with dilated cardiomyopathy, with large QRS and who were refractory to medication, were the first authors to demonstrate the correlation between biventricular stimulation and the improvement in heart performance. After that, many studies were published to assess the effects of biventricular stimulation<sup>16-18</sup>.</p>
      <p>Despite the proven benefits of CRT<sup>16-18</sup>, approximately 20-30% of patients do not respond to this therapy (they are called "non-responders"<sup>19,20</sup>). That makes it necessary to adopt additional selection criteria to identify patients that will benefit from cardiac resynchronization<sup>21,22</sup>.</p>
      <p>According to the Brazilian Guidelines for Implantable Electronic Cardiac Devices (2007)<sup>23</sup>, recommendation I and the evidence level A for CRT is: Patients in functional class III or IV (NYHA), with optimized medication therapy, ejection fraction <underline>&lt;</underline> 35%, sinus rhythm and duration of the QRS complex &gt; 150 ms or QRS between 120 and 150 ms, with proof of dyssynchrony by the imaging method.</p>
      <p>The use of echocardiography as a supplemental method for indication of the CRT was described for the first time in 2005, in the CARE-HF (Cardiac Resynchronization - Heart Failure)<sup>24</sup> study, which compared the effect of CRT on the risk of complications and death. Countless echocardiographic techniques have been proposed to quantify the ventricular dyssynchrony, with the purpose of optimizing the selection of patients for the CRT<sup>25</sup>.</p>
      <p>Pitzalis et al<sup>26</sup> used the monodimensional mode (M mode) to assess the intraventricular dyssynchrony, considering values above 130 ms as abnormal. The pulsed Doppler is an echocardiographic method used to assess the intraventricular dyssynchrony<sup>24</sup>, by the electromechanical delay difference between the right and left ventricles, indicating dyssynchrony when the values above 40 ms<sup>19,25</sup>.</p>
      <p>The echocardiogram is also used in the evaluation of the mitral regurgitation. Breithardt et al<sup>27</sup> studied its acute effects on CRT, assessing 24 patients subjected to resynchronization, who did not show significant reduction in the level of mitral insufficiency, directly associated with the dP/dt increase.</p>
      <p>The tissue Doppler allows identifying and measuring the myocardial motion speed, by positioning the cursor in the segment that you wish to evaluate<sup>28</sup>. Bax et al<sup>19</sup>, in a study with 85 patients for a 6-month follow-up period after the CRT, demonstrated, among four basal segments, sensitiveness and specificity of 80% as predictor of clinical improvement and 92% as predictor of reverse modeling, in the presence of interval greater than 65 ms and evaluated by the tissue Doppler.</p>
      <p>
        <bold>Objective</bold>
      </p>
      <p>The objective of this work is to analyze the use of the echocardiogram in the evaluation of the cardiac resynchronization therapy, in patients with refractory HF, in a short follow-up period (ten days) and after two years of evolution.</p>
      <p>
        <bold>Case selection and method</bold>
      </p>
      <p>The study was based on 20 patients, to whom a biventricular pacemaker implant had been prescribed, through the coronary sinus, for cardiac resynchronization therapy, aged 59.70 &#177; 12.59 years on average, 16 of which (80%) were male, monitored for a two-year period. The cardiomyopathy had been caused by ischemia in 10 patients (50%), by Chagas's disease in 6 patients (30%) and by other unknown factors in 4 patients (20%). Fifteen patients (75%) were in functional class III and 5 (25%) in functional class IV, when the resynchronization therapy was prescribed to them.</p>
      <p>
        <bold>Study dynamics</bold>
      </p>
      <p>When the CRT was prescribed, the patients' medical history was prepared. Then, they underwent clinical tests and were classified according to the New York Heart Association (NYHA), for a functional evaluation. After the initial clinical evaluation, the Minnesota Living with Heart Failure Questionnaire (MLWHFQ) was filled out. The distance traveled was determined (in meters, through a six-minute walking test) and the two-dimensional echo-Doppler-cardiogram was performed, with the use of a 3.5 Hz transducer in the Nemio equipment (Toshiba). Ten days after the biventricular pacemaker was implanted, the entire initial evaluation was repeated, and the same process was repeated after two years.</p>
      <p>
        <bold>Echocardiographic evaluation</bold>
      </p>
      <p>
        <bold>Evaluation of the left ventricular function</bold>
      </p>
      <p>The ejection fraction of the left ventricle was evaluated through the two-dimensional method (Simpson's method). In addition, the myocardial performance index (or Tei index) was calculated, for evaluating the systole and diastole functions of the left ventricle, calculated by the sum of isovolumetric contraction and relaxation times divided by the ejection time, considering values below 0.40 as normal.</p>
      <p>
        <bold>Evaluation of the reverse remodeling</bold>
      </p>
      <p>The reverse remodeling is characterized by a reduction of more than 15% of the final systolic volume, evaluated by the echocardiogram, between the pre-operation and post-operation periods.</p>
      <p>
        <bold>Evaluation of the mitral regurgitation</bold>
      </p>
      <p>The mitral regurgitation evaluation was conducted with the use of the color flow mapping in the four-chamber apical and parasternal cross-section slices. The mitral regurgitation was quantified by the ratio of the regurgitating jet area to the left atrium area, considering that the regurgitation is minor when the percentage area is smaller than 20% and important when it is larger than 40%.</p>
      <p>
        <bold>Evaluation of the interventricular dyssynchrony</bold>
      </p>
      <p>The pulsed Doppler method was used to analyze the interventricular dyssynchrony, through the electromechanical delay difference between left and right ventricles, by measuring the time interval between the R wave of the electrocardiogram and the beginning of the speed curve of the aortic flow and pulmonary flow. Interval above 40 ms indicates interventricular dyssynchrony.</p>
      <p>
        <bold>Evaluation of the intraventricular dyssynchrony</bold>
      </p>
      <p>The M-mode and the tissue-Doppler methods were used to assess the intraventricular dyssynchrony. In the short-axis parasternal slice, at the level of the papillary muscles, the M-mode evaluation was performed, by measuring the time interval between the maximum contraction of the septum and the posterior wall of the left ventricle (S/PW), considering as dyssynchrony values above 130 ms. In the tissue-Doppler evaluation, the myocardial speeds are obtained in the apical plane of the basal segments of septal, lateral, anterior and inferior walls, and the time interval between the beginning of the QRS complex and the peak of the myocardial systolic wave of the tissue-Doppler is measured in the different segments. There is significant dyssynchrony when the time interval difference is higher than 65 ms between any segments assessed. The values considered were obtained by the average of four consecutive heart beats.</p>
      <p>
        <bold>Statistical analysis</bold>
      </p>
      <p>The Statistical Package for Social Sciences (SPSS) for Windows, version 11.5, was used for analyzing the data. To run the tests, bilateral hypotheses and a significance level &#945; = 5% were taken into account. Descriptive statistics were used to assess the frequency, average and standard deviation of the variables of interest. The t-test for independent samples was used for the comparison of the age-variable averages. The Mann-Whitney test was used to analyze clinical, electrocardiographic and echocardiographic variables, when they were quantitative variables.</p>
      <p>The Chi-square test was used to check if the proportions of the categories of clinical and echocardiographic variables, when they were qualitative variables, were homogenous in groups of interest. For comparing the functional class, "living with heart failure" score and traveled distance, QRS time length variables and echocardiographic variables (ejection fraction, mitral insufficiency, interventricular dyssynchrony, posterior wall/septum distance, myocardial performance index, final diastolic and systolic volume, diastolic diameter of the left ventricle and tissue-Doppler throughout time [before operation, 10 days and two years]), the NON-PARAMETRIC ANOVA (Analysis of Variance) was used.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>In this work, 20 patients in whom a biventricular pacemaker was implanted were monitored for two years. There were neither complications with respect to the surgical procedure nor deaths in the 10-day follow-up period after operation.</p>
      <p>An analysis was conducted to assess the behavior of clinical, electrocardiographic and echocardiographic variables, comparing them in the period before and after the operation (10 days after and two days after). When the pacemaker was implanted, 15 patients were in functional class III; 5 in functional class IV; 13 patients (65%) showed improvement in the functional class in the first post-operation evaluation; 6 (30%) kept the same functional class; and there was worsening of the functional class in one patient (5%). In the two-year follow-up period, 10 patients showed no change in the functional class, compared to the previous evaluation, and there was improvement in three patients and worsening in two of them.</p>
      <p>In the assessment of variables throughout time, it was possible to find statistically significant differences for the following variables: functional class, living with heart failure score, QRX complex time length, ejection fraction, inter and intraventricular dyssynchrony (time between contraction of septum and the posterior wall - M mode and tissue-Doppler) and diastolic diameter of left ventricle. <xref ref-type="table" rid="en_18t01-body2">Table 1</xref> shows the mean and the standard deviation for each one of the variables in the pre-operation period, in the 10 days after the surgery and two years after the CRT.</p>
      <p content-type="asset">
        <table-wrap id="en_18t01-body2">
          <graphic xlink:href="1678-4170-abc-94-01-0119-00018-gt01-en.jpg"/></table-wrap>
      </p>
      <p>The average time length of the QRS complex in the pre-operation period was 154.5 &#177; 18.48 ms; 129.0 &#177; 22.91 ms in the 10-day evaluation; and 134.0 &#177; 24.14 ms in the two-year evaluation, with p &lt; 0,001.</p>
      <p>When the QRS complex time length and functional class were compared, it was possible to notice that patients with QRS time length, showed a higher functional class, in the pre-operation evaluation (p = 0.006), but there was not statistically significant difference in the post-operation periods (<xref ref-type="table" rid="t2-body2">Table 2</xref>).</p>
      <table-wrap id="t2-body2">
        <graphic xlink:href="1678-4170-abc-94-01-0119-00018-gt02-en.jpg"/></table-wrap>
      <p>For the functional class, QRX complex time length and tissue-Doppler variables, it was possible to notice statistically significant differences between the pre-operation period and the evaluation 10 days after the procedure, as well as between the pre-operation period and two years after the post-implantation. However, there was no difference between the 10-day and two-year periods. For these variables, it was possible to see a reduction in the measures after the surgical intervention, which remained stable after two years. In <xref ref-type="fig" rid="en_18ch01-body2">Chart 1</xref>, it is possible to analyze the variation noticed throughout time by the evaluation of the tissue-Doppler.</p>
      <p content-type="asset">
        <fig id="en_18ch01-body2">
          <graphic xlink:href="1678-4170-abc-94-01-0119-00018-gf01-en.jpg"/></fig>
      </p>
      <p>For the ejection fraction, we noticed no statistically significant difference between the pre-operation period and the ten days after the operation, but there were differences between the pre-operation period and the next two years and between the ten days and the two subsequent years.</p>
      <p>It was possible to find statistically significant differences between all periods in the assessment of the following variables: Interventricular dyssynchrony, posterior wall/septum distance and living with heart failure score. Therefore, there was a significant reduction when we compare the pre-operation period and the 10 days after that and the pre-operation period and the two subsequent years in the three variables analyzed. However, there was a statistically significant increase in the values found between the 10-day period and two-year period of these variables.</p>
      <p>In the assessment of the LVDD, there was significant reduction between the pre-operation period and the 10-day period and significant increase between the 10-day period and the two-year period, so there is no statistically significant difference between initial and final measurements.</p>
      <p>In our case selection, 5 patients (25%) died. In <xref ref-type="table" rid="t3-body2">Table 3</xref>, it is possible to see that the proportion of men in the death group to men in the non-death group is homogeneous (86.7% and 60%, respectively), with predominance of men in both groups, and with no significant difference between the proportion of men to women in the two groups (p = 0.249).</p>
      <table-wrap id="t3-body2">
        <graphic xlink:href="1678-4170-abc-94-01-0119-00018-gt03-en.jpg"/></table-wrap>
      <p>For the cause (etiology) variable, in the non-death group, the number of patients with dilated and ischemic etiology is larger than in the death-group. In Chagas-disease etiology, the situation is the opposite: 80% of patients are in the death group, and there is a statistically significant difference in the proportions of the etiology types according to death (p = 0.018).</p>
      <p>There was no statistically significant difference between the death and non-death groups for the mitral insufficiency variable and QRS complex time length variable, both in the pre-operation period and after 10 days.</p>
      <p><xref ref-type="table" rid="en_18t04-body2">Table 4</xref> shows the comparisons of the following variables: functional class, living with heart failure score, traveled distance, interventricular dyssynchrony, posterior wall/septum distance, myocardial performance index, final systolic and diastolic volume and tissue-Doppler in the pre-operation period and 10 days after surgery.</p>
      <p content-type="asset">
        <table-wrap id="en_18t04-body2">
          <graphic xlink:href="1678-4170-abc-94-01-0119-00018-gt04-en.jpg"/></table-wrap>
      </p>
      <p>There was no statistically significant difference between the death and non-death group, in the assessment of pre-operation variables. However, in the 10-day assessment, there was a statistically significant difference in the living with heart failure score, and the living with heart failure score of death group patients is higher than that of non-death group patients. The same thing happened for the tissue-Doppler variable, in which the values of the death group suggested greater intraventricular dyssynchrony.</p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>HF is a serious public health problem, with high morbidity-mortality rate and costs above 33 billion dollars a year<sup>1</sup>.</p>
      <p>In around 25-50% of HF patients, there is the presence of intraventricular conduction disturbance, in which the left bundle branch block occurs more frequently. Baldasseroni et al<sup>7</sup>, assessed, in 2002, the link between the LBBB and the mortality rate and demonstrated that LBBB is an unfavorable prognostic marker and regardless of age, HF level and use of therapy.</p>
      <p>Nowadays, the CRT has been used as an auxiliary therapy in patients that are refractory to optimized medication therapy<sup>16,18</sup>.</p>
      <p>In our case selection, we assessed 20 patients, 15 of which were in functional class III and 5 in functional class IV, who had undergone the CRT through the coronary sinus, and without complications inherent in the procedure. All patients show LBBB in the electrocardiogram, with QRS complex time length above 120 ms.</p>
      <p>Despite the proven benefits of CRT<sup>16-18</sup>, approximately 20-30% of patients do not respond to this therapy<sup>19,20</sup>. That makes it necessary to implement additional criteria to identify patients that will be entitled to this benefit<sup>21,22</sup>.</p>
      <p>In this case selection, in the follow-up period of 10 days after implantation of the biventricular pacemaker, there was an improvement in the functional class in 13 patients (65%), worsening in one of them (5%) and in 6 patients (30%) the functional class remained unchanged. After two years of evolution, 8 patients were in functional class II and 7 in functional class III. The mortality in this period was of 25% (5 patients), with no correlation between the death and the worsening of the functional class.</p>
      <p>In the assessment of the causes of the cardiomyopathy, Reuter et al<sup>29</sup> associated the dilated cardiomyopathy with the better clinical response of CRT. Martinelli Filho et al<sup>30</sup>, in a study including patients whose heart failure resulted from Chagas's disease, there was a significant reduction in the functional class in patients with dilated cardiomyopathy, besides the fact that this etiology had been a predictor, regardless of clinical improvement.</p>
      <p>Among the patients of this study, the ones whose cardiomyopathy had been caused by Chagas's disease were linked to the higher death rate, with statistically significant when compared to patients with ischemic and dilated etiology.</p>
      <p>Shamim et al<sup>8</sup> assessed, in a 36-month follow-up period, the association between the QRS duration and the mortality, where patients with QRS below 120 ms showed a mortality of 20%; QRS between 120 and 160 ms, 36%; and above 160 ms, the mortality was of 58%<sup>31</sup>.</p>
      <p>In our case selection, comparing the functional class and the QRS time length, a statistically significant difference was found between the groups in the pre-CRT period, where the group with QRS <underline>&gt;</underline> 160 ms showed a worse functional class<sup>31</sup>. In the 10-day follow-up period, there was no statistically significant difference between the two groups. In the two-year assessment, there was only one patient alive with QRS time length above 160 ms.</p>
      <p>Many echocardiographic techniques have been used to quantify the interventricular and intraventricular dyssynchronies, with the purpose of optimizing the selection of patients for CRT.</p>
      <p>The assessment of the interventricular dyssynchrony by using the M-mode of the echocardiogram (S/PW) was proposed by Pitzalis et al<sup>26</sup> - in a group of 20 patients. All responders had an S/PW distance of more than 130 ms.</p>
      <p>In this test, we had a statistically significant reduction in the values of the S/PW value, when the three analysis periods were compared. However, there was no statistical difference in the death group compared to the non-death group in the pre-operation evaluation and in the 10-day follow-up period. In patients with ischemic cardiomyopathy, the S/PW variable analysis may be impaired by segmental contraction changes.</p>
      <p>With the pulsed Doppler, Chung et al<sup>32</sup> showed the link between this variable and the clinical improvement and reverse remodeling.</p>
      <p>In our group, there was a statistically significant difference in the pre-operation period and in the two post-operation evaluation periods. However, when we compared the values of the death group and non-death group, there was no statistically significant difference.</p>
      <p>In the mitral regurgitation evaluation, in 10 days, 11 patients showed no changes in the mitral regurgitation level. In the two-year follow-up period, 10 patients had the same level of regurgitation that they had in the pre-operation period in the first follow-up period (10 days) and subsequent worsening in the two-year assessment. In the comparison of the death-group and non-death group, the mitral insufficiency value was not statistically significant.</p>
      <p>In a study with 85 patients, in a 6-month follow-up period after the CRT, Bax et al<sup>19</sup> demonstrated the sensitiveness and specificity of 80% as a predictor of clinical improvement and 92% of sensitiveness and specificity as a predictor of reverse remodeling, when the dyssynchrony value assessed by the tissue-Doppler was greater than 65 ms.</p>
      <p>In our group, we had a statistically significant difference in the variation of the tissue-Doppler of the pre-operation and post-operation periods. And, it was possible to consider that the tissue-Doppler evaluation in the first days after the procedure is a useful tool to assess the CRT's efficiency. When compared to the death and non-death groups, the tissue-Doppler revealed an increase associated with the death group.</p>
      <p>In this study, more advanced echocardiography techniques, such as the three-dimensional echocardiogram and the bidimensional strain, were not used. The use of such techniques, in the future, may expand the application of echocardiography in the evaluation of patients for CRT.</p>
      <p>
        <bold>Study limitations</bold>
      </p>
      <p>- Small case selection, with absence in the control group;</p>
      <p>- Echocardiographic evaluation without intra and interobserver reproducibility study.</p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>In the assessment of the echocardiographic parameters evaluated herein, only the intraventricular dyssynchrony through the tissue Doppler method after the procedure was capable of predicting the cardiac resynchronization efficiency with respect to mortality. The echocardiographic parameters are not associated with the clinical improvement.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of master submitted by Viviane Cordeiro Veiga, from Universidade Estadual de Campinas.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Evaluaci&#243;n ecocardiogr&#225;fica de la terapia de resincronizaci&#243;n cardiaca: dos a&#241;os de seguimiento</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: La terapia de resincronizaci&#243;n cardiaca (TRC) es una opci&#243;n efectiva para los pacientes con insuficiencia cardiaca (IC) avanzada. Se vienen estudiando criterios cl&#237;nicos, electrocardiogr&#225;ficos y ecocardiogr&#225;ficos en el intento de seleccionar a los pacientes que ser&#225;n beneficiados con la TRC, siendo el ecocardiograma un m&#233;todo utilizado tanto en la selecci&#243;n como en la evaluaci&#243;n de este tratamiento. OBJETIVO: El objetivo de este trabajo es analizar la utilizaci&#243;n del ecocardiograma en la evaluaci&#243;n de la TRC, en el seguimiento de diez d&#237;as y luego de dos a&#241;os de evoluci&#243;n. M&#201;TODOS: Fueron evaluados 20 pacientes sometidos a la TRC, por un per&#237;odo de dos a&#241;os, siendo el 80% de sexo masculino. Se aplic&#243; el Cuestionario de Calidad de Vida de Minnesota, el test de caminata de 6 minutos y se realiz&#243; el ecodopplercardiograma bidimensional. Diez d&#237;as tras el implante del marcapasos biventricular, as&#237; como dos a&#241;os despu&#233;s, se repiti&#243; la evaluaci&#243;n inicial. RESULTADOS: En dos a&#241;os, 5 pacientes (25%) obitaron; 4 presentaban miocardiopat&#237;a de etiolog&#237;a chag&#225;sica. No hubo alteraci&#243;n estad&#237;sticamente significativa de la fracci&#243;n de eyecci&#243;n entre el per&#237;odo preoperatorio y los diez d&#237;as siguientes, pero s&#237; una alteraci&#243;n significativa en los per&#237;odos de preoperatorio, dos a&#241;os y diez d&#237;as y dos a&#241;os. En el seguimiento de diez d&#237;as, hubo un empeoramiento de la disincron&#237;a intraventricular evaluada por doppler tisular, as&#237; como la puntuaci&#243;n en el escore de calidad de vida fue mayor en el grupo &#243;bito. CONCLUSI&#211;N: De los par&#225;metros ecocardiogr&#225;ficos evaluados, solamente la evaluaci&#243;n de la disincron&#237;a intraventricular por doppler tisular tras el procedimiento fue capaz de predecir la eficacia de la TRC en relaci&#243;n a la mortalidad.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Ecocardiograf&#237;a</kwd>
        <kwd>insuficiencia cardiaca</kwd>
        <kwd>volumen sist&#243;lico</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <fn id="top-body3">
          <label>
            <bold>Evaluaci&#243;n ecocardiogr&#225;fica de la terapia de resincronizaci&#243;n cardiaca: dos a&#241;os de seguimiento</bold>
          </label>
          <p>
            <bold>Viviane Cordeiro Veiga<sup>I, II</sup>; Salom&#243;n Soriano Ordinola Rojas<sup>I, II</sup>; Fernando S&#233;rgio Oliva de Souza<sup>II</sup>; Reinaldo Wilson Vieira<sup>I</sup>; Amilton Silva Junior<sup>II</sup>; Marcelo Luiz Patr&#237;cio<sup>II</sup>; Elias C&#233;sar Hauy Marum<sup>II</sup>; Henry Abensur<sup>II</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Universidade Estadual de Campinas (UNICAMP), SP - Brasil</p>
      <p><sup>II</sup>Real e Benem&#233;rita Associa&#231;&#227;o Portuguesa de Benefic&#234;ncia - S&#227;o Paulo, SP - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO: </bold> La terapia de resincronizaci&#243;n cardiaca (TRC) es una opci&#243;n efectiva para los pacientes con insuficiencia cardiaca (IC) avanzada. Se vienen estudiando criterios cl&#237;nicos, electrocardiogr&#225;ficos y ecocardiogr&#225;ficos en el intento de seleccionar a los pacientes que ser&#225;n beneficiados con la TRC, siendo el ecocardiograma un m&#233;todo utilizado tanto en la selecci&#243;n como en la evaluaci&#243;n de este tratamiento.</p>
      <p><bold>OBJETIVO: </bold> El objetivo de este trabajo es analizar la utilizaci&#243;n del ecocardiograma en la evaluaci&#243;n de la TRC, en el seguimiento de diez d&#237;as y luego de dos a&#241;os de evoluci&#243;n.</p>
      <p><bold>M&#201;TODOS:</bold> Fueron evaluados 20 pacientes sometidos a la TRC, por un per&#237;odo de dos a&#241;os, siendo el 80% de sexo masculino. Se aplic&#243; el Cuestionario de Calidad de Vida de Minnesota, el test de caminata de 6 minutos y se realiz&#243; el ecodopplercardiograma bidimensional. Diez d&#237;as tras el implante del marcapasos biventricular, as&#237; como dos a&#241;os despu&#233;s, se repiti&#243; la evaluaci&#243;n inicial.</p>
      <p><bold>RESULTADOS:</bold> En dos a&#241;os, 5 pacientes (25%) obitaron; 4 presentaban miocardiopat&#237;a de etiolog&#237;a chag&#225;sica. No hubo alteraci&#243;n estad&#237;sticamente significativa de la fracci&#243;n de eyecci&#243;n entre el per&#237;odo preoperatorio y los diez d&#237;as siguientes, pero s&#237; una alteraci&#243;n significativa en los per&#237;odos de preoperatorio, dos a&#241;os y diez d&#237;as y dos a&#241;os. En el seguimiento de diez d&#237;as, hubo un empeoramiento de la disincron&#237;a intraventricular evaluada por doppler tisular, as&#237; como la puntuaci&#243;n en el escore de calidad de vida fue mayor en el grupo &#243;bito.</p>
      <p><bold>CONCLUSI&#211;N: </bold> De los par&#225;metros ecocardiogr&#225;ficos evaluados, solamente la evaluaci&#243;n de la disincron&#237;a intraventricular por doppler tisular tras el procedimiento fue capaz de predecir la eficacia de la TRC en relaci&#243;n a la mortalidad. (Arq Bras Cardiol 2010; 94(1) : 112-119)</p>
      <p><bold>Palabras clave: </bold> Ecocardiograf&#237;a, insuficiencia cardiaca/terapia, volumen sist&#243;lico.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>La insuficiencia cardiaca (IC) es una condici&#243;n cl&#237;nica de alta morbimortalidad que aqueja aproximadamente a 23 millones de personas en el mundo<sup>1</sup>. Seg&#250;n el DATASUS<sup>2</sup>, en Brasil, en el per&#237;odo de enero a julio de 2008, hubo 147.348 internaciones derivadas de la IC.</p>
      <p>Entre los portadores de IC, los trastornos de conducci&#243;n intraventricular con prolongaci&#243;n del complejo QRS est&#225;n presentes en alrededor de un 25-50% de los pacientes<sup>3-6</sup>, siendo m&#225;s frecuente el bloqueo de rama izquierda (BRI)<sup>6,7</sup>.</p>
      <p>La conducci&#243;n del est&#237;mulo el&#233;ctrico est&#225; relacionada a la eficiencia funcional cardiaca. En pacientes con una alteraci&#243;n en la conducci&#243;n normal del est&#237;mulo, puede haber interferencia en la coordinaci&#243;n contr&#225;ctil auricular y/o ventricular - denominada disincron&#237;a cardiaca - y, de este modo, alterar la funci&#243;n mioc&#225;rdica<sup>8,9</sup>.</p>
      <p>Cazeau et al<sup>10</sup>, en 1994, describieron la estimulaci&#243;n del ventr&#237;culo izquierdo a trav&#233;s del seno coronario, con marcapasos tetrac&#225;mara. En 2001, la <italic>Food and Drug Administration</italic> (FDA) aprob&#243; para uso cl&#237;nico la terapia de resincronizaci&#243;n cardiaca (TRC), con m&#225;s de 270.000 pacientes ya sometidos al procedimiento<sup>11</sup>. En Brasil, seg&#250;n Pach&#243;n et al<sup>12</sup>, en el per&#237;odo de 1994 a 2006, se realizaron 2.180 implantes de resincronizadores. En la actualidad, la TRC, por medio de la estimulaci&#243;n cardiaca con marcapasos biventricular, se ha utilizado como terapia adyuvante en los pacientes refractarios al tratamiento medicamentoso optimizado<sup>13,14</sup>.</p>
      <p>Bakker et al<sup>15</sup> fueron los primeros autores que demostraron correlaci&#243;n entre la estimulaci&#243;n biventricular y la mejora en el desempe&#241;o cardiaco, al analizar 5 pacientes portadores de miocardiopat&#237;a dilatada, con QRS ancho y refractariedad al tratamiento medicamentoso. A partir de ese momento, se publicaron diversos estudios para evaluar los efectos de la estimulaci&#243;n biventricular<sup>16-18</sup>.</p>
      <p>A pesar de los beneficios comprobados de la TRC<sup>16-18</sup>, aproximadamente 20-30% de los pacientes no responden a esta terap&#233;utica y son denominados "no respondedores"<sup>19,20</sup>, lo que resulta en la necesidad de adoptar criterios de selecci&#243;n adicionales para identificar a los pacientes que ser&#225;n beneficiados con la resincronizaci&#243;n cardiaca<sup>21,22</sup>.</p>
      <p>De acuerdo con las Directrices Brasile&#241;as de Dispositivos Cardiacos Electr&#243;nicos Implantables (2007)<sup>23</sup>, la recomendaci&#243;n I y el nivel de evidencia A para la TRC es: pacientes en clase funcional III &#243; IV (NYHA), con tratamiento medicamentoso optimizado, fracci&#243;n de eyecci&#243;n <underline>&lt;</underline> 35%, ritmo sinusal y duraci&#243;n del complejo QRS &gt; 150 ms o QRS entre 120 y 150 ms, con comprobaci&#243;n de disincron&#237;a por m&#233;todos de imagen.</p>
      <p>La utilizaci&#243;n de la ecocardiograf&#237;a como m&#233;todo complementario para indicaci&#243;n de la TRC se describi&#243; por primera vez en 2005, en el estudio CARE-HF (<italic>Cardiac Resynchronization - Heart Failure</italic>)<sup>24</sup>, que compar&#243; el efecto de la TRC en el riesgo de complicaciones y mortalidad. Est&#225;n siendo propuestas numerosas t&#233;cnicas ecocardiogr&#225;ficas para cuantificar la disincron&#237;a ventricular, con el objeto de optimizar la selecci&#243;n de los pacientes para TRC<sup>25</sup>.</p>
      <p>Pitzalis et al<sup>26</sup> utilizaron el modo unidimensional (modo M) para evaluar la disincron&#237;a intraventricular, considerando anormales los valores superiores a 130 ms. El doppler pulsado es un m&#233;todo ecocardiogr&#225;fico utilizado como evaluaci&#243;n de la disincron&#237;a interventricular<sup>24</sup>, por medio de la diferencia del atraso electromec&#225;nico entre los ventr&#237;culos derecho e izquierdo, indicando disincron&#237;a cuando los valores superan los 40 ms<sup>19,25</sup>.</p>
      <p>El ecocardiograma tambi&#233;n se utiliza en la evaluaci&#243;n de la regurgitaci&#243;n mitral. Breithardt et al<sup>27</sup> estudiaron sus efectos agudos en la TRC, evaluando a 24 pacientes sometidos a la resincronizaci&#243;n, que presentaban una reducci&#243;n significativa del grado de insuficiencia mitral, directamente relacionada al aumento del dP/dt.</p>
      <p>El doppler tisular permite identificar y medir la velocidad de movimiento del miocardio, posicionando el cursor en el segmento que se desea evaluar<sup>28</sup>. Bax et al<sup>19</sup>, en un estudio con 85 pacientes durante 6 meses de seguimiento tras la TRC, demostraron, entre cuatro segmentos basales, sensibilidad y especificidad del 80% como predictor de mejora cl&#237;nica y del 92% como predictor de remodelamiento reverso, en presencia de un intervalo mayor de 65 ms y evaluado por doppler tisular.</p>
      <p>
        <bold>Objetivo</bold>
      </p>
      <p>El objetivo de este trabajo es la utilizaci&#243;n del ecocardiograma en la evaluaci&#243;n de la terapia de resincronizaci&#243;n cardiaca, en pacientes portadores de IC refractaria, en el seguimiento a corto plazo (diez d&#237;as) y tras dos a&#241;os de evoluci&#243;n.</p>
      <p>
        <bold>M&#233;todo</bold>
      </p>
      <p>Fueron estudiados 20 pacientes, con indicaci&#243;n de implante de marcapasos biventricular a trav&#233;s del seno coronario, para terapia de resincronizaci&#243;n cardiaca, con una edad promedio de 59,70 &#177; 12,59 a&#241;os, siendo 16 (80%) de sexo masculino, con seguimiento durante un per&#237;odo de dos a&#241;os. La etiolog&#237;a de la miocardiopat&#237;a era isqu&#233;mica en 10 pacientes (50%), chag&#225;sica en 6 (30%) e idiop&#225;tica en 4 (20%). Quince pacientes (75%) se hallaban en clase funcional III y 5 (25%) en clase funcional IV, en el momento de la indicaci&#243;n de la terapia de resincronizaci&#243;n.</p>
      <p>
        <bold>Din&#225;mica del estudio</bold>
      </p>
      <p>En ocasi&#243;n de la indicaci&#243;n de la TRC, los pacientes fueron sometidos a la anamnesis y al examen cl&#237;nico y clasificados, seg&#250;n la <italic>New York Heart Association</italic> (NYHA), para evaluaci&#243;n funcional. Tras la evaluaci&#243;n cl&#237;nica inicial, se aplic&#243; el Cuestionario de Calidad de Vida de Minnesota, se determin&#243; la distancia recorrida (en metros, por el test de caminata de 6 minutos) y se realiz&#243; el ecocardiograma doppler bidimensional, utiliz&#225;ndose un transductor de 3,5 Hz en el aparato Nemio (Toshiba). Diez d&#237;as tras el implante del marcapasos biventricular, se repiti&#243; toda la evaluaci&#243;n inicial, lo mismo que ocurri&#243; luego de dos a&#241;os.</p>
      <p>
        <bold>Evaluaci&#243;n ecocardiogr&#225;fica</bold>
      </p>
      <p>
        <bold>Evaluaci&#243;n de la funci&#243;n ventricular izquierda</bold>
      </p>
      <p>La evaluaci&#243;n de la fracci&#243;n de eyecci&#243;n del ventr&#237;culo izquierdo se llev&#243; a cabo mediante el m&#233;todo bidimensional (m&#233;todo de Simpson). Adem&#225;s, se realiz&#243; el c&#225;lculo del &#237;ndice de performance mioc&#225;rdica (o &#237;ndice de Tei), para evaluaci&#243;n de las funciones sist&#243;lica y diast&#243;lica del ventr&#237;culo izquierdo, calculado mediante la suma de los tiempos de contracci&#243;n y de relajaci&#243;n isovolum&#233;tricos divididos por el tiempo de eyecci&#243;n, consider&#225;ndose normales valores menores que 0,40.</p>
      <p>
        <bold>Evaluaci&#243;n del remodelamiento reverso</bold>
      </p>
      <p>El remodelamiento reverso se caracteriza por la disminuci&#243;n de m&#225;s del 15% del volumen sist&#243;lico final, evaluado por ecocardiograma, entre los per&#237;odos pre y postoperatorio.</p>
      <p>
        <bold>Evaluaci&#243;n de la regurgitaci&#243;n mitral</bold>
      </p>
      <p>La evaluaci&#243;n de la regurgitaci&#243;n mitral se realiz&#243; utilizando el mapeo de flujo color en los cortes paraesternal, longitudinal y apical de cuatro c&#225;maras. La cuantificaci&#243;n de la regurgitaci&#243;n mitral se realiz&#243; por medio de la relaci&#243;n entre el &#225;rea del jet regurgitante y el &#225;rea de la aur&#237;cula izquierda, consider&#225;ndose regurgitaci&#243;n de grado discreto cuando el &#225;rea porcentual es menor que el 20%, e importante cuando es mayor del 40%.</p>
      <p>
        <bold>Evaluaci&#243;n de la disincron&#237;a interventricular</bold>
      </p>
      <p>La disincron&#237;a interventricular se analiz&#243; a trav&#233;s del doppler pulsado, mediante la diferencia del atraso electromec&#225;nico entre los ventr&#237;culos derecho e izquierdo, midi&#233;ndose el intervalo de tiempo entre la onda R del electrocardiograma y el inicio de la curva de velocidad del flujo a&#243;rtico y del flujo pulmonar. Un intervalo superior a 40 ms es indicativo de disincron&#237;a interventricular.</p>
      <p>
        <bold>Evaluaci&#243;n de la disincron&#237;a intraventricular</bold>
      </p>
      <p>La evaluaci&#243;n de la disincron&#237;a intraventricular fue realizada en modo M y mediante doppler tisular. En el corte paraesternal eje corto, a nivel de los m&#250;sculos papilares, se realiz&#243; la evaluaci&#243;n con el modo M, midi&#233;ndose el intervalo de tiempo entre la contracci&#243;n m&#225;xima del septum y de la pared posterior del ventr&#237;culo izquierdo (S/PP) y consider&#225;ndose disincron&#237;a valores superiores a 130 ms. En la evaluaci&#243;n con doppler tisular, se obtienen las velocidades del miocardio, en el plano apical, de los segmentos basales de las paredes septal, lateral, anterior e inferior, y se realiza la medici&#243;n del intervalo de tiempo entre el inicio del complejo QRS hasta el pico de la onda sist&#243;lica mioc&#225;rdica del doppler tisular (Sm) en los diferentes segmentos. Cuando el valor de la diferencia de intervalos de tiempo es superior a 65 ms entre cualquiera de los segmentos evaluados, se trata de una disincron&#237;a significativa. Los valores considerados se obtuvieron del promedio de cuatro latidos consecutivos.</p>
      <p>
        <bold>An&#225;lisis estad&#237;stico</bold>
      </p>
      <p>El an&#225;lisis de los datos fue llevado a cabo con el paquete estad&#237;stico SPSS (<italic>Statistical Package for Social Sciences</italic>) <italic>for Windows</italic> versi&#243;n 11.5. Todos los test fueron realizados, consider&#225;ndose hip&#243;tesis bilaterales y asumiendo nivel de significancia &#945; = 5%. Se utiliz&#243; la estad&#237;stica descriptiva para evaluar la frecuencia, el promedio, y el desviaci&#243;n est&#225;ndar de las variables de inter&#233;s. Las comparaciones de los promedios de la variable edad se realizaron mediante el test-t para muestras independientes. Con relaci&#243;n a las variables cl&#237;nicas, electrocardiogr&#225;ficas y ecocardiogr&#225;ficas, cuando eran cuantitativas, se analizaban con el test de Mann-Whitney.</p>
      <p>El test de Chi-cuadrado se utiliz&#243; para verificar si las proporciones de las categor&#237;as de las variables cl&#237;nicas y ecocardiogr&#225;ficas, cuando eran cualitativas, eran homog&#233;neas en los grupos de inter&#233;s. Para las comparaciones de las variables clase funcional, escore de calidad de vida y distancia recorrida, duraci&#243;n del complejo QRS, y de las variables ecocardiogr&#225;ficas - fracci&#243;n de eyecci&#243;n, insuficiencia mitral, disincron&#237;a interventricular, distancia septum/pared posterior, &#237;ndice de performance mioc&#225;rdica, volumen diast&#243;lico y sist&#243;lico final, di&#225;metro diast&#243;lico del ventr&#237;culo izquierdo y doppler tisular a lo largo del tiempo (preoperatorio, 10 d&#237;as y dos a&#241;os) -, se utiliz&#243; el ANOVA NO PARAM&#201;TRICO.</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>En este trabajo, se realiz&#243; el seguimiento por un per&#237;odo de dos a&#241;os, en 20 pacientes sometidos a implante de marcapasos biventricular. No hubo complicaciones relacionadas al procedimiento quir&#250;rgico, ni &#243;bitos en los primeros 10 d&#237;as de seguimiento postoperatorio.</p>
      <p>Se analiz&#243; el comportamiento de las variables cl&#237;nicas, electrocardiogr&#225;ficas y ecocardiogr&#225;ficas, compar&#225;ndolas en el pre y postoperatorio (10 d&#237;as despu&#233;s y tras dos a&#241;os). Al momento del implante del marcapaso, 15 pacientes se encontraban en clase funcional III; 5, en clase funcional IV; 13 pacientes (65%) presentaron mejor&#237;a en la clase funcional en la primera evaluaci&#243;n postoperatoria; 6 (30%) mantuvieron la misma clase funcional; y en un paciente (5%) hubo un empeoramiento. En el seguimiento de dos a&#241;os, 10 pacientes no presentaron alteraci&#243;n de la clase funcional, cuando se compar&#243; con la evaluaci&#243;n previa; en tres se observ&#243; una mejor&#237;a y dos empeoraron.</p>
      <p>Al evaluarlas a lo largo del tiempo, encontramos diferencias estad&#237;sticamente significativas para las variables: clase funcional, escore de calidad de vida, duraci&#243;n del complejo QRS, fracci&#243;n de eyecci&#243;n, disincron&#237;a inter e intraventricular (tiempo entre contracci&#243;n del septum y de la pared posterior - modo M y doppler tisular) y di&#225;metro diast&#243;lico del ventr&#237;culo izquierdo. La <xref ref-type="table" rid="es_18t01-body3">Tabla 1</xref> presenta el promedio y el desviaci&#243;n est&#225;ndar para cada una de las variables en el per&#237;odo preoperatorio, en los 10 d&#237;as posteriores a la cirug&#237;a y dos a&#241;os despu&#233;s de la TRC.</p>
      <p content-type="asset">
        <table-wrap id="es_18t01-body3">
          <graphic xlink:href="1678-4170-abc-94-01-0119-00018-gt01-es.jpg"/></table-wrap>
      </p>
      <p>La duraci&#243;n promedio del complejo QRS en el preoperatorio era de 154,5 &#177; 18,48 ms; 129,0 &#177; 22,91 ms en la evaluaci&#243;n a los 10 d&#237;as; y 134,0 &#177; 24,14 ms luego de dos a&#241;os, con p &lt; 0,001.</p>
      <p>Cuando se compar&#243; la clase funcional y la duraci&#243;n del complejo QRS, se observ&#243; que pacientes con duraci&#243;n del QRS <underline>&gt;</underline> 160 ms presentaron clase funcional mayor, en la evaluaci&#243;n preoperatoria (p = 0,006), pero no se observ&#243; una diferencia estad&#237;sticamente significativa en los per&#237;odos de postoperatorio (<xref ref-type="table" rid="t2-body3">Tabla 2</xref>).</p>
      <table-wrap id="t2-body3">
        <graphic xlink:href="1678-4170-abc-94-01-0119-00018-gt02-es.jpg"/></table-wrap>
      <p>Para las variables clase funcional, duraci&#243;n del complejo QRS y doppler tisular, se observaron diferencias estad&#237;sticamente significativas entre el per&#237;odo preoperatorio y la evaluaci&#243;n de 10 d&#237;as tras el procedimiento, as&#237; como entre el per&#237;odo preoperatorio y los dos a&#241;os siguientes al implante. Sin embargo, no hubo diferencia entre los per&#237;odos de 10 d&#237;as y dos a&#241;os. En esas variables se observ&#243; una disminuci&#243;n de las medidas luego de la intervenci&#243;n quir&#250;rgica, que se mantuvo estable luego de dos a&#241;os. En el <xref ref-type="fig" rid="g1-body3">Gr&#225;fico 1</xref>, se puede analizar la variaci&#243;n observada a lo largo del tiempo en la evaluaci&#243;n mediante doppler tisular.</p>
      <fig id="g1-body3">
        <graphic xlink:href="1678-4170-abc-94-01-0119-00018-gf01-es.jpg"/></fig>
      <p>Para la variable fracci&#243;n de eyecci&#243;n, no se observ&#243; diferencia estad&#237;sticamente significativa entre el preoperatorio y los diez d&#237;as siguientes a la operaci&#243;n, pero se encontraron diferencias entre el per&#237;odo preoperatorio y los dos a&#241;os siguientes y entre los diez d&#237;as y los dos a&#241;os posteriores.</p>
      <p>Se hallaron diferencias estad&#237;sticamente significativas entre todos los per&#237;odos en la evaluaci&#243;n de las variables: disincron&#237;a interventricular, distancia septum/pared posterior y escore de calidad de vida. Hubo, por lo tanto, una disminuci&#243;n significativa, si comparamos el preoperatorio y los 10 d&#237;as siguientes y el preoperatorio y los dos a&#241;os siguientes, en las tres variables analizadas. No obstante, hubo un aumento estad&#237;sticamente significativo de los valores encontrados entre los per&#237;odos 10 d&#237;as y dos a&#241;os de esas variables.</p>
      <p>En la evaluaci&#243;n de la variable DDVI, hubo una disminuci&#243;n significativa entre los per&#237;odos preoperatorio y 10 d&#237;as y un aumento significativo entre 10 d&#237;as y dos a&#241;os, de modo que no existe diferencia estad&#237;sticamente significativa entre la medida inicial y la final.</p>
      <p>En nuestra casu&#237;stica, tuvimos 5 pacientes (25%) que obitaron. En la <xref ref-type="table" rid="t3-body3">Tabla 3</xref> se observa que la proporci&#243;n de hombres dentro de los grupos con &#243;bito y sin &#243;bito es homog&#233;nea (86,7% y 60%, respectivamente), con predominio de hombres en ambos grupos, sin diferencia significativa entre la proporci&#243;n de hombres y mujeres en los dos grupos (p = 0,249).</p>
      <table-wrap id="t3-body3">
        <graphic xlink:href="1678-4170-abc-94-01-0119-00018-gt03-es.jpg"/></table-wrap>
      <p>Para la variable etiolog&#237;a, en el grupo sin &#243;bito, el n&#250;mero de pacientes con etiolog&#237;a dilatada e isqu&#233;mica es mayor que en el grupo con &#243;bito. En la etiolog&#237;a chag&#225;sica ocurre lo contrario, con un 80% de los pacientes en el grupo con &#243;bito, marcando una diferencia estad&#237;sticamente significativa en las proporciones de los tipos de etiolog&#237;a seg&#250;n &#243;bito (p = 0,018).</p>
      <p>No se evidenci&#243; diferencia estad&#237;sticamente significativa entre los grupos con &#243;bito y sin &#243;bito para las variables insuficiencia mitral y duraci&#243;n del complejo QRS, tanto en el per&#237;odo preoperatorio como luego de 10 d&#237;as.</p>
      <p>En la <xref ref-type="table" rid="es_18t04-body3">Tabla 4</xref> se encuentran las comparaciones de las variables clase funcional, escore de calidad de vida, distancia recorrida, disincron&#237;a interventricular, distancia septum/pared posterior, &#237;ndice de performance mioc&#225;rdica, volumen diast&#243;lico y sist&#243;lico final y doppler tisular en los per&#237;odos preoperatorio y 10 d&#237;as tras la cirug&#237;a.</p>
      <p content-type="asset">
        <table-wrap id="es_18t04-body3">
          <graphic xlink:href="1678-4170-abc-94-01-0119-00018-gt04-es.jpg"/></table-wrap>
      </p>
      <p>No existi&#243; diferencia estad&#237;sticamente significativa entre los grupos con &#243;bito y sin &#243;bito, en la evaluaci&#243;n de las variables en el preoperatorio. Sin embargo, en la evaluaci&#243;n de 10 d&#237;as, se observ&#243; una diferencia estad&#237;sticamente significativa en la variable escore de calidad de vida, donde los pacientes del grupo con &#243;bito poseen una puntuaci&#243;n mayor en el escore de calidad de vida con relaci&#243;n al grupo sin &#243;bito. Lo mismo se verifica para la variable doppler tisular, en que el grupo con &#243;bito present&#243; valores que suger&#237;an mayor disincron&#237;a intraventricular.</p>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>La IC constituye un grave problema de la salud p&#250;blica, con elevada morbimortalidad y costos superiores a 33 billones de d&#243;lares por a&#241;o<sup>1</sup>.</p>
      <p>Cerca del 25-50% de los portadores de IC, presenta un trastorno de conducci&#243;n intraventricular, siendo el m&#225;s frecuente el bloqueo de rama izquierda. Baldasseroni et al<sup>7</sup>, en 2002, evaluaron la asociaci&#243;n de BRI y mortalidad y demostraron que el BRI es un marcador pron&#243;stico desfavorable e independiente de edad, grado de IC y uso de terap&#233;utica.</p>
      <p>Actualmente, la TRC se utiliza como adyuvante en los pacientes con IC refractarios al tratamiento medicamentoso optimizado<sup>16,18</sup>.</p>
      <p>En nuestra casu&#237;stica, evaluamos 20 pacientes, de los cuales 15 estaban en clase funcional III y 5 en clase funcional IV, sometidos a la TRC a trav&#233;s del seno coronario, sin complicaciones inherentes al procedimiento. Todos los pacientes presentaban BRI en el electrocardiograma, y duraci&#243;n del complejo QRS superior a 120 ms.</p>
      <p>A pesar de los beneficios comprobados de la TRC<sup>16-18</sup>, aproximadamente 20-30% de los pacientes no responden a esta terap&#233;utica<sup>19,20</sup>, por lo que es necesario implementar criterios adicionales para identificar a los pacientes que ser&#225;n beneficiados<sup>21,22</sup>.</p>
      <p>En esta casu&#237;stica, en el seguimiento de 10 d&#237;as tras el implante del marcapasos biventricular, hubo mejora de la clase funcional en 13 pacientes (65%), deterioro en uno de ellos (5%) y en 6 pacientes (30%) la clase funcional permaneci&#243; inalterada. Luego de dos a&#241;os de evoluci&#243;n, 8 pacientes estaban en clase funcional II y 7 en clase funcional III. La mortalidad en ese per&#237;odo fue del 25% (5 pacientes), sin correlaci&#243;n entre el &#243;bito y el deterioro de la clase funcional.</p>
      <p>En la evaluaci&#243;n de la etiolog&#237;a de la miocardiopat&#237;a, Reuter et al<sup>29</sup> asociaron la miocardiopat&#237;a dilatada a la mejor respuesta cl&#237;nica de la TRC. Martinelli Filho et al<sup>30</sup>, en un estudio que incluy&#243; pacientes con etiolog&#237;a chag&#225;sica, encontraron una reducci&#243;n significativa de la clase funcional en pacientes con miocardiopat&#237;a dilatada, adem&#225;s de constituir esta etiolog&#237;a un predictor independiente de mejor&#237;a cl&#237;nica.</p>
      <p>Entre los pacientes de este estudio, los que presentaron etiolog&#237;a chag&#225;sica estuvieron relacionados a la mayor tasa de &#243;bito, con una diferencia estad&#237;sticamente significativa, si se comparan con los pacientes con etiolog&#237;a isqu&#233;mica y dilatada.</p>
      <p>Shamim et al<sup>8</sup> evaluaron, en 36 meses de seguimiento, la asociaci&#243;n entre duraci&#243;n del QRS y mortalidad, donde pacientes con QRS menor de 120 ms presentaron una mortalidad del 20%; con QRS entre 120 y 160 ms, del 36%; y con QRS mayor de 160 ms, la mortalidad fue del 58%<sup>31</sup>.</p>
      <p>En nuestra casu&#237;stica, comparando clase funcional y duraci&#243;n del QRS, se hall&#243; una diferencia estad&#237;sticamente significativa entre los grupos en el per&#237;odo pre TRC, donde el grupo con QRS <underline>&gt;</underline> 160 ms presentaba peor clase funcional<sup>31</sup>. En el seguimiento de 10 d&#237;as, no hubo diferencia estad&#237;sticamente significativa entre los dos grupos. Solamente un paciente con duraci&#243;n del QRS superior a 160 ms sobrevivi&#243; a los dos a&#241;os de evoluci&#243;n.</p>
      <p>Con el objetivo de optimizar la selecci&#243;n de los pacientes para TRC, se han utilizado diversas t&#233;cnicas ecocadiogr&#225;ficas para cuantificar las disincron&#237;as inter e intraventricular.</p>
      <p>La evaluaci&#243;n de la disincron&#237;a interventricular con la utilizaci&#243;n del modo M del ecocardiograma (S/PP) fue propuesta por Pitzalis et al<sup>26</sup> En un grupo de 20 pacientes, todos los respondedores presentaban distancia S/PP superior a 130 ms.</p>
      <p>En este ensayo, tuvimos una disminuci&#243;n estad&#237;sticamente significativa en los valores de la variable S/PP, si se comparan los tres per&#237;odos de an&#225;lisis. No obstante, no hubo diferencia estad&#237;stica en el grupo con &#243;bito comparado al grupo sin &#243;bito en las evaluaciones de preoperatorio y en el seguimiento de 10 d&#237;as. En pacientes con miocardiopat&#237;a isqu&#233;mica, el an&#225;lisis de la variable S/PP puede estar perjudicado por alteraciones de la contracci&#243;n segmentaria.</p>
      <p>Con el doppler pulsado, Chung et al<sup>32</sup> mostraron la relaci&#243;n de esa variable con mejor&#237;a cl&#237;nica y remodelamiento reverso.</p>
      <p>En nuestro grupo, hubo una diferencia estad&#237;sticamente significativa en el preoperatorio y en los dos per&#237;odos de evaluaci&#243;n postoperatoria. No obstante, relacionando los valores entre los grupos con &#243;bito y sin &#243;bito, no existi&#243; diferencia estad&#237;sticamente significativa.</p>
      <p>En la evaluaci&#243;n de la insuficiencia mitral, en 10 d&#237;as, 11 pacientes no presentaron cambios en el grado de regurgitaci&#243;n mitral. En el seguimiento de dos a&#241;os, 10 pacientes se hallaban con el mismo grado de regurgitaci&#243;n que presentaban en el preoperatorio en el primer seguimiento (10 d&#237;as) y posterior deterioro en la evaluaci&#243;n de dos a&#241;os. Cuando se compararon los grupos con &#243;bito y sin &#243;bito, la insuficiencia mitral no present&#243; un valor estad&#237;sticamente significativo.</p>
      <p>En un estudio con 85 pacientes, en seguimiento de 6 meses post TRC, Bax et al<sup>19</sup> demostraron sensibilidad y especificidad del 80% como predictor de mejor&#237;a cl&#237;nica y un 92% de sensibilidad y especificidad para predecir remodelamiento reverso, cuando el valor de la disincron&#237;a evaluada por el doppler tisular era superior a 65 ms.</p>
      <p>En nuestro grupo, tuvimos diferencia estad&#237;sticamente significativa en la variaci&#243;n del doppler tisular de pre y postoperatorio, pudiendo considerarse que la evaluaci&#243;n del doppler tisular en los primeros d&#237;as post procedimiento es una herramienta &#250;til en la evaluaci&#243;n de la eficacia de la TRC. Cuando se compararon los grupos con &#243;bito y sin &#243;bito, el doppler tisular mostr&#243; aumento relacionado al grupo con &#243;bito.</p>
      <p>En este estudio, no se utilizaron t&#233;cnicas m&#225;s avanzadas de ecocardiograf&#237;a, como el ecocardiograma tridimensional y el <italic>strain</italic> bidimensional, lo que, en el futuro, podr&#225; ampliar la actuaci&#243;n de la ecocardiograf&#237;a en la evaluaci&#243;n de los pacientes para TRC.</p>
      <p>
        <bold>Limitaciones del estudio</bold>
      </p>
      <p>- Casu&#237;stica peque&#241;a, con ausencia de grupo control;</p>
      <p>- Evaluaci&#243;n ecocardiogr&#225;fica sin estudio de reproducibilidad intra e inter-observador.</p>
      <p>
        <bold>Conclusi&#243;n</bold>
      </p>
      <p>En la valoraci&#243;n ecocardiogr&#225;fica de los par&#225;metros evaluados en este estudio, solo la disincron&#237;a intraventricular mediante doppler tisular tras el procedimiento fue capaz de predecir la eficacia de la terapia de resincronizaci&#243;n cardiaca con relaci&#243;n a la mortalidad. Los par&#225;metros ecocardiogr&#225;ficos no se correlacionaron con la mejor&#237;a cl&#237;nica.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio no tuvo fuentes de financiaci&#243;n externas.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo forma parte de la tesis de Maestr&#237;a de Viviane Cordeiro Veiga en la Universidad Estadual de Campinas.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
</article>
